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Abstract 	  Sirtuin-­‐1	  (Sirt-­‐1),	  an	  NAD+-­‐dependent	  deacetylase,	  maintains	  energy	  homeostasis	  upon	  stress-­‐induced	  decline	  in	  energy	  levels.	  Sirt-­‐1	  possesses	  many	  other	  functions	  ranging	  from	  regulating	  cellular	  proliferation	  and	  apoptosis	  to	  maintaining	  glucose	  and	  lipid	  metabolism.	  By	  deacetylating	  its	  target	  proteins,	  Sirt-­‐1	  can	  also	  increase	  the	  lifespan	  of	  lower	  organisms	  such	  as	  yeast,	  flies,	  and	  worms.	  However,	  lifespan-­‐prolonging	  ability	  of	  Sirt-­‐1	  in	  rodent	  models	  and	  human	  subjects	  has	  been	  investigated,	  exhibiting	  only	  partially	  promising	  results.	  	  Contrary	  to	  its	  role	  in	  increasing	  lifespan	  in	  rodents	  and	  humans,	  Sirt-­‐1	  has	  exhibited	  positive	  results	  on	  prolonging	  the	  health-­‐span	  of	  these	  model	  organisms	  by	  delaying	  or	  inhibiting	  the	  development	  of	  diseases	  and	  disorders	  that	  present	  themselves	  with	  increasing	  age.	  Drug	  mediated	  Sirt-­‐1	  activation	  via	  resveratrol	  and	  Sirt-­‐1	  activation	  through	  calorie	  restriction	  were	  shown	  to	  bring	  a	  healthy	  balance	  to	  glucose	  and	  lipid	  metabolism	  especially	  in	  rodents	  fed	  on	  high-­‐fat	  diet.	  Currently,	  Sirt-­‐1	  is	  investigated	  as	  a	  target	  gene	  for	  the	  treatment	  of	  Type-­‐2	  Diabetes	  in	  multiple	  clinical	  trials.	  	  In	  this	  study,	  we	  investigated	  the	  role	  of	  the	  Sirtuin-­‐1	  in	  the	  maintenance	  of	  intestinal	  epithelium.	  In	  our	  study,	  we	  utilized	  intestinal	  organoid	  models	  grown	  from	  isolated	  crypts	  of	  mouse	  small	  intestine.	  We	  performed	  knockdown	  of	  Sirt-­‐1	  at	  mRNA	  level	  via	  lentiviral	  shRNA.	  Additionally,	  we	  targeted	  Sirt-­‐1	  activity	  by	  applying	  resveratrol	  to	  the	  culture	  media	  of	  mouse	  intestinal	  organoids.	  Our	  main	  aim	  was	  to	  address	  how	  manipulations	  of	  Sirt-­‐1	  expression	  or	  activity	  would	  affect	  the	  function	  of	  intestinal	  stem	  cells	  and	  Paneth	  cells	  located	  in	  the	  crypt	  tips	  of	  intestinal	  organoids.	  Furthermore,	  we	  were	  interested	  in	  how	  these	  changes	  would	  alter	  organoid	  viability	  and	  crypt	  regeneration.	  	  In	  this	  study,	  we	  demonstrate	  that	  Sirt-­‐1	  is	  a	  fundamental	  gene	  for	  mouse	  intestinal	  organoid	  viability	  as	  well	  as	  organoid	  crypt	  regeneration.	  We	  also	  show	  that	  Sirt-­‐1	  controls	  crypt	  regeneration	  by	  regulating	  Paneth	  cell	  differentiation	  and	  thus	  intestinal	  stem	  cell	  niche	  conditions	  in	  the	  crypt	  bottoms	  of	  mouse	  intestinal	  organoids.	  	  Activation	  of	  Sirt-­‐1	  by	  resveratrol	  decreases	  total	  Paneth	  cell	  number	  in	  a	  crypt	  bottom	  leading	  to	  the	  relative	  retardation	  of	  crypt	  regeneration	  as	  well	  as	  the	  reduction	  in	  crypt	  size.	  High	  concentrations	  of	  resveratrol	  resulted	  in	  death	  of	  intestinal	  organoids,	  probably	  due	  to	  complete	  loss	  of	  Paneth	  cells.	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I.	  Abbreviations	  	  
Akt:	  Protein	  kinase	  B	  
AMP:	  Adenosine	  monophosphate	  
AMPK:	  AMP-­‐activated	  protein	  kinase	  
APC:	  Adenomatous	  polyposis	  coli	  
BMP:	  Bone	  morphogenetic	  protein	  
BSA:	  Bovine	  Serum	  Albumin	  
cAMP:	  Cyclic	  adenosine	  monophosphate	  
CR:	  Calorie	  Restriction	  
DMEM:	  Dulbecco's	  Modified	  Eagle	  Medium	  
DR:	  Dietary	  Restriction	  
EB:	  Ethylium	  Bromide	  
EDTA:	  Ethylenediaminetetraacetic	  acid	  
EGF:	  Epidermal	  Growth	  Factor	  
FOXO:	  Forkhead	  Box	  O	  
GH:	  Growth	  hormone	  
GSK-­‐3β:	  Glycogen	  synthase	  kinase-­‐	  3-­‐beta	  
HEK293T:	  Human	  embryonic	  kidney	  293	  T	  cell	  line	  
IGF-­‐1:	  Insulin-­‐like	  Growth	  Factor-­‐1	  
IIS:	  Insulin/IGF-­‐1	  Signaling	  
ISC:	  Intestinal	  Stem	  Cell	  
Km:	  Michaelis	  constant	  
Lgr5:	  Leucine-­‐Rich	  Repeat	  Containing	  G	  Protein-­‐Coupled	  Receptor	  5	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MES:	  2-­‐(N-­‐morpholino)ethanesulfonic	  acid	  
miRNA:	  microRNA	  
mTDNA:	  Mitochondrial	  DNA	  
mTOR:	  Mammalian	  target	  of	  rapamycin	  
mTORC1:	  mammalian	  target	  of	  rapamycin	  complex	  1	  
mTORC2:	  mammalian	  target	  of	  rapamycin	  complex	  2	  
NAD:	  Nicotinamide	  adenine	  dinucleotide	  
NADH:	  Reduced	  nicotinamide	  adenine	  dinucleotide	  	  
NF-­‐κB:	  Nuclear	  Factor	  Kappa	  from	  B	  cells	  
NIH	  3T3:	  Mouse	  embryonic	  fibroblast	  cell	  line	  
P/S:	  Penicillin/Streptomycin	  
PBS:	  Phosphate	  Buffered	  Saline	  
PGC-­‐1α:	  Peroxisome	  proliferator-­‐activated	  receptor	  gamma	  coactivator	  1-­‐alpha	  
PI3K:	  Phosphatidylinositol	  3-­‐kinase	  
PVDF:	  Polyvinylidene	  difluoride	  




STAC:	  Sirtuin-­‐1	  Activating	  Compound	  
TB:	  Terrific	  Broth	  
TBS:	  Tris	  Buffered	  Saline	  
TBST:	  Tris	  Buffered	  Saline	  +	  Tween	  20	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ULK1:	  Serine/threonine-­‐protein	  kinase	  ULK1	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1.	  Review	  of	  Literature	  
	  
1.1.	  Aging	  	  Aging	  is	  the	  progressive	  decline	  of	  physiological	  integrity	  in	  an	  organism.	  The	  decline	  is	  manifested	  by	  weakening	  of	  organ	  systems	  resulting	  in	  an	  increased	  susceptibility	  to	  death.	  Aging	  also	  produces	  the	  greatest	  risk	  factor	  for	  the	  development	  of	  pathologies	  such	  as	  cancer,	  diabetes,	  cardiovascular	  disorders,	  and	  neurodegenerative	  diseases.1	  The	  nature	  of	  aging	  is	  regulated	  by	  genetic	  factors	  and	  biological	  pathways.	  By	  targeting	  molecules	  functioning	  in	  these	  pathways,	  scientists	  were	  able	  to	  discover	  that	  the	  rate	  of	  aging	  can	  be	  controlled	  exogenously	  to	  some	  extend.	  In	  time,	  cells	  accumulate	  genetic	  damage	  and	  this	  damage	  manifests	  phenotypic	  characteristics	  on	  the	  organism,	  which	  is	  basically	  named	  as	  aging.	  Slowing	  down	  the	  rate	  of	  genetic	  damage	  accumulation	  in	  cellular	  DNA	  or	  inhibiting	  the	  effects	  of	  these	  damages	  can	  make	  it	  possible	  to	  diminish	  the	  biological	  impact	  of	  aging	  on	  an	  organism.	  	  Lopez-­‐Otin	  et	  al	  identified	  nine	  hallmarks	  of	  aging	  as	  the	  main	  contributors	  to	  this	  phenomenon.1	  Each	  of	  these	  biological	  concepts	  has	  to	  meet	  three	  main	  criteria	  to	  be	  considered	  as	  a	  hallmark.	  It	  should	  first	  manifest	  during	  normal	  aging	  process.	  When	  exacerbated	  in	  an	  experimental	  setting,	  it	  should	  also	  accelerate	  aging.	  Finally,	  it	  should	  also	  be	  able	  to	  slow	  down	  aging	  when	  it	  is	  experimentally	  ameliorated.	  However,	  third	  criterion	  is	  not	  so	  strict	  as	  some	  of	  these	  hallmarks	  have	  not	  yet	  exhibited	  a	  potential	  in	  slowing	  down	  aging	  and	  increasing	  lifespan	  in	  experimental	  settings.1	  According	  to	  this	  three	  criteria	  the	  selected	  hallmarks	  of	  aging	  are	  as	  follows:	  genomic	  instability,	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telomere	  attrition,	  epigenetic	  alterations,	  loss	  of	  proteostasis,	  deregulated	  nutrient	  sensing,	  mitochondrial	  dysfunction,	  cellular	  senescence,	  stem	  cell	  exhaustion,	  and	  altered	  intercellular	  communication.1	  This	  thesis	  will	  touch	  upon	  a	  few	  of	  these	  hallmarks.	  
1.1.1.	  Genomic	  Instability	  increases	  with	  Age	  	  Nuclear	  and/or	  mitochondrial	  DNA	  can	  accumulate	  genetic	  damage,	  which	  affect	  the	  rate	  of	  mammalian	  aging	  and	  the	  susceptibility	  of	  mammals	  to	  develop	  aging-­‐associated	  pathologies.	  DNA	  damage	  accumulation	  at	  abnormal	  levels	  can	  be	  the	  causative	  factor	  for	  the	  occurrence	  of	  premature	  aging.2	  Most	  of	  the	  accumulated	  genetic	  mutations	  that	  damage	  nuclear	  DNA	  are	  in	  the	  form	  of	  somatic	  mutations.3	  Other	  forms	  of	  errors	  that	  cause	  damage	  are	  chromosomal	  aneuploidies	  and	  copy	  number	  variations.4-­‐5	  These	  abnormalities	  have	  also	  been	  discovered	  as	  associated	  with	  mammalian	  aging.	  	  Damage	  in	  critical	  genes	  and	  transcriptional	  pathways	  can	  impair	  the	  proper	  functioning	  of	  cells.	  If	  these	  cells	  are	  not	  destroyed	  through	  the	  mechanisms	  of	  natural	  killing	  such	  as	  apoptosis,	  they	  may	  also	  alter	  the	  structure	  and	  the	  function	  of	  the	  tissues	  they	  belong	  to.	  	  When	  there	  is	  an	  error	  in	  replication	  of	  cellular	  DNA,	  repair	  mechanisms	  come	  into	  play	  and	  manage	  to	  correct	  this	  error,	  inhibiting	  the	  formation	  of	  a	  new	  DNA	  with	  undesired	  genetic	  alteration.	  However,	  if	  the	  components	  of	  DNA	  repair	  mechanisms	  are	  altered	  or	  left	  partially	  or	  completely	  dysfunctional	  due	  to	  damage,	  this	  leads	  to	  accelerated	  DNA	  damage	  accumulation	  and	  observed	  as	  augmented	  aging	  phenotype.1	  This	  phenomenon	  has	  been	  observed	  in	  mice	  models	  and	  also	  explains	  the	  development	  of	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some	  of	  the	  human	  progeroid	  syndromes	  such	  as	  Werner	  syndrome	  and	  Bloom	  syndrome.6-­‐7	  Alterations	  in	  the	  coding	  sequence	  of	  mitochondrial	  DNA	  (mtDNA)	  also	  affect	  the	  rate	  of	  aging.8	  Most	  of	  these	  alterations,	  in	  the	  form	  of	  genetic	  mutations,	  are	  usually	  caused	  by	  early-­‐in-­‐life	  replication	  errors.	  Some	  of	  mtDNA	  mutations	  can	  lead	  to	  human	  multisystem	  disorders	  and	  faster	  aging.	  Studies	  that	  were	  performed	  with	  mice	  lacking	  mitochondrial	  DNA	  polymerase	  γ	  have	  shown	  that	  these	  mice	  exhibit	  the	  characteristics	  of	  premature	  aging.9	  Lifespan	  of	  mice	  was	  also	  found	  to	  be	  reduced	  due	  to	  the	  accumulation	  of	  point	  mutations	  and	  deletions	  in	  mtDNA.9	  Research	  is	  now	  focused	  on	  reversing	  this	  premature	  aging	  process	  by	  targeting	  the	  mutations	  in	  mtDNA	  in	  order	  to	  observe	  if	  mice	  lifespan	  can	  be	  extended.1	  
1.1.2.	  Epigenetic	  Modifications	  play	  a	  key	  role	  in	  Aging	  	  Changes	  in	  epigenetic	  modifications	  can	  highly	  affect	  mammalian	  aging	  and	  rate	  at	  which	  aging-­‐associated	  diseases	  advance.	  Epigenetic	  modifications	  may	  include	  DNA	  methylation,	  histone	  modification,	  and	  chromatin	  remodeling.107	  Conservation	  of	  epigenetic	  patterns	  native	  to	  the	  organism’s	  physiology	  is	  maintained	  by	  a	  set	  of	  enzymes,	  which	  consists	  of	  DNA	  methyltransferases,	  histone	  acetylases,	  deacetylases,	  methylases,	  demethylases,	  and	  chromatin	  remodeling	  protein	  complexes.1	  Alterations	  in	  these	  enzymes	  can	  improve	  or	  vanish	  the	  ability	  of	  the	  organism	  to	  conserve	  the	  epigenetic	  patterns	  leading	  to	  increases	  or	  reduction	  in	  lifespan.	  	  Deletion	  of	  histone	  methylation	  complex	  components	  has	  been	  shown	  to	  extend	  lifespan	  in	  nematodes	  and	  flies.10-­‐11	  Inhibition	  of	  histone	  demethylases	  in	  worms	  has	  the	  potential	  to	  increase	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lifespan	  through	  its	  impact	  on	  longevity	  pathways	  such	  as	  insulin/IGF-­‐1	  signaling	  pathway.12	  NAD+	  dependent	  deacetylase	  coding	  genes	  Sirtuins	  have	  also	  been	  shown	  to	  possess	  potential	  in	  affecting	  organismal	  longevity.1	  Sirt1,	  a	  member	  of	  sirtuin	  gene	  family,	  is	  the	  closest	  homolog	  of	  Sir2,	  which	  was	  found	  to	  increase	  replicative	  lifespan	  of	  
Saccharomyces	  cerevisiae	  when	  overexpressed.13	  Following	  research	  was	  done	  to	  show	  that	  Sir2	  homologs	  sir-­‐2.1	  and	  dSir2	  could	  also	  increase	  the	  lifespan	  upon	  activation	  in	  worm	  and	  fly	  respectively.14-­‐15	  However,	  these	  results	  were	  later	  challenged	  and	  that	  the	  previous	  findings	  on	  the	  role	  of	  Sir2	  homologs	  in	  prolonging	  lifespan	  were	  found	  to	  be	  the	  result	  of	  confounding	  genetic	  background	  differences	  instead	  of	  gene	  overexpression.16	  Sirtuin	  genes	  definitely	  play	  a	  role	  in	  improving	  several	  of	  phenotypic	  outcomes	  resulting	  due	  to	  aging	  in	  rodent	  models.	  While	  overexpression	  of	  SIRT1	  is	  found	  to	  have	  no	  direct	  effect	  on	  rodent	  aging,	  it	  still	  prevents/slows	  down	  the	  development	  of	  aging-­‐associated	  diseases.17	  SIRT1	  activation	  functions	  as	  a	  protective	  barrier	  against	  the	  advancing	  of	  age-­‐related	  pathologies	  through	  its	  ability	  to	  improve	  genomic	  stability	  and	  metabolic	  efficiency.18-­‐19	  SIRT3	  and	  SIRT6,	  other	  genes	  of	  sirtuin	  family,	  can	  enhance	  overall	  health	  and/or	  longevity	  of	  mice	  by	  using	  epigenetic	  mechanisms.1	  SIRT6	  has	  been	  shown	  to	  regulate	  genomic	  stability,	  NF-­‐κB	  signaling,	  and	  glucose	  homeostasis	  through	  histone	  H3K9	  deacetylation.20-­‐22	  Mice	  deficient	  in	  SIRT6	  were	  found	  to	  be	  experiencing	  accelerated	  aging.23	  In	  parallel	  to	  this	  finding,	  mice	  overexpressing	  SIRT6	  exhibited	  longer	  lifespan	  compared	  to	  control	  mice.24	  SIRT3,	  located	  primarily	  in	  mitochondria,	  has	  been	  shown	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to	  mediate	  the	  beneficial	  effects	  of	  calorie	  restriction	  on	  the	  lifespan	  of	  mice	  by	  deacetylating	  mitochondrial	  proteins.25	  	  Transcriptional	  alterations	  are	  also	  seen	  with	  increasing	  age.26	  Microarray	  studies	  show	  clear	  differences	  in	  mRNA	  levels	  between	  young	  and	  old	  tissues	  of	  same	  species.	  Age-­‐related	  transcriptional	  alterations	  can	  occur	  in	  genes,	  which	  code	  for	  proteins	  that	  function	  in	  inflammatory,	  mitochondrial,	  and	  lysosomal	  degradation	  pathways.27	  Changes	  in	  transcriptional	  levels	  in	  an	  aging	  organism	  can	  also	  be	  seen	  in	  non-­‐coding	  sequences,	  especially	  in	  miRNAs.	  miRNAs	  are	  known	  to	  be	  closely	  associated	  with	  aging	  and	  their	  activity	  can	  influence	  the	  rate	  of	  aging	  of	  an	  organism.	  miRNAs	  achieve	  this	  ability	  by	  targeting	  proteins	  that	  function	  in	  longevity	  pathways	  or	  by	  affecting	  stem	  cell	  behavior.28-­‐30	  
1.1.3.	  Decline	  in	  Proteostasis	  is	  seen	  in	  Aging	  Mammalians	  	  Degree	  of	  impaired	  protein	  homeostasis	  or	  proteostasis	  is	  another	  factor	  that	  affects	  the	  rate	  of	  mammalian	  aging.31	  Cellular	  proteins	  go	  through	  quality	  control	  processes,	  which	  check	  the	  functional	  and	  structural	  integrity	  of	  the	  proteins.	  These	  processes	  maintain	  and	  ensure	  that	  proteins	  translated	  are	  folded	  properly	  so	  that	  they	  can	  function	  in	  their	  assigned	  biological	  mechanism(s).	  Proteostasis	  is	  the	  concept	  of	  stabilizing	  correctly	  folded	  proteins	  and	  degrading	  some	  of	  the	  misfolded	  proteins.1	  Proteostasis	  also	  functions	  to	  restore	  the	  misfolded	  proteins,	  if	  not	  direct	  them	  for	  degradation.1	  This	  function	  prevents	  the	  accumulation	  of	  misfolded	  proteins	  as	  well	  as	  protects	  and	  stabilizes	  the	  properly	  folded	  ones	  inside	  the	  cells.	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Aging	  is	  a	  natural	  phenomenon	  that	  impairs	  proper	  functioning	  of	  proteostasis.32	  When	  proteostasis	  is	  not	  maintained,	  accumulation	  of	  misfolded	  proteins	  might	  be	  toxic	  to	  the	  organism	  and	  it	  can	  lead	  to	  age-­‐associated	  diseases	  such	  as	  Alzheimer’s	  disease	  and	  Parkinson’s	  disease	  in	  humans.31	  
1.1.4.	  Reduction	  in	  Intrinsic	  Nutrient	  Sensor	  Activity	  Slows	  Down	  Aging	  	  
1.1.4.1.	  Insulin	  and	  IGF-­‐1	  Signaling	  (IIS)	  	  Anabolic	  signaling	  maintained	  by	  one	  of	  the	  most	  evolutionarily	  conserved	  pathways	  of	  evolution,	  insulin	  and	  IGF-­‐1	  signaling	  (IIS)	  pathway,	  accelerates	  aging.1	  Main	  targets	  of	  this	  pathway	  responsible	  for	  informing	  the	  cells	  on	  the	  presence	  of	  glucose	  are	  the	  transcription	  factors	  belonging	  the	  FOXO	  family	  and	  the	  mTOR	  complexes,	  which	  were	  also	  shown	  to	  have	  an	  impact	  on	  aging.33-­‐34	  Genetic	  manipulations	  or	  activity	  reducing	  mutations	  that	  occur	  in	  the	  coding	  sequences	  of	  the	  members	  of	  IIS	  signaling	  pathway	  including	  the	  growth	  hormone	  (GH),	  IGF-­‐1	  receptor,	  insulin	  receptor	  as	  well	  as	  the	  downstream	  effectors	  of	  this	  pathway	  Akt,	  mTOR,	  and	  FOXO	  were	  shown	  to	  extend	  longevity	  in	  different	  model	  organisms.33-­‐34	  In	  parallel	  to	  this	  finding,	  dietary	  restriction	  (DR)	  or	  calorie	  restriction	  (CR),	  which	  directly	  reduces	  activity	  in	  IIS	  pathway,	  increases	  lifespan	  in	  similar	  model	  organisms	  including	  but	  not	  limited	  to	  worms,	  flies,	  mice,	  and	  non-­‐human	  primates.34-­‐35	  	  Reduction	  in	  IIS	  signaling	  pathway	  has	  direct	  benefits	  on	  organismal	  longevity.	  Contrary	  to	  this	  phenomenon,	  GH	  and	  IGF-­‐1	  levels	  were	  also	  shown	  to	  decline	  both	  during	  normal	  aging	  and	  in	  mice	  with	  premature	  aging.36	  Thus,	  constitutive	  reduction	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of	  IIS	  extends	  lifespan	  whereas	  reduced	  IIS	  signaling	  is	  a	  characteristic	  of	  time-­‐dependent	  physiological	  aging.	  	  Reason	  why	  IIS	  signaling	  is	  reduced	  in	  normal	  aging	  can	  be	  explained	  as	  a	  natural	  defensive	  mechanism	  of	  organism	  against	  aging.	  IIS	  signaling	  is	  reduced	  to	  inhibit	  or	  slow	  down	  aging,	  which	  leads	  to	  minimizing	  cellular	  growth	  and	  metabolism	  in	  the	  circumstance	  of	  systemic	  damage.37	  According	  to	  this	  theory,	  organisms	  with	  a	  constitutively	  reduced	  IIS	  signaling	  retain	  longer	  lifespan	  because	  they	  possess	  lower	  rates	  of	  cellular	  growth	  and	  metabolic	  activity,	  which	  is	  translated	  to	  lower	  rates	  of	  cellular	  damage.	  Analogous	  to	  this	  biology,	  physiologically	  aged	  organisms	  try	  to	  reduce	  the	  activity	  of	  IIS	  signaling	  pathway	  in	  order	  to	  extend	  their	  lifespan.	  However,	  extremely	  low	  expression	  levels	  of	  the	  member	  genes	  of	  this	  pathway	  can	  be	  lethal	  to	  the	  organism	  as	  it	  will	  highly	  reduce	  cellular	  growth	  and	  inhibit	  the	  normal	  functioning	  of	  metabolism.	  For	  example,	  mice	  with	  null	  mutations	  in	  either	  of	  PI3K	  or	  Akt	  genes	  die	  at	  embryonic	  stage.38	  Mice	  with	  certain	  progeroid	  syndromes	  may	  exhibit	  very	  low	  levels	  of	  IGF-­‐1	  and	  administering	  IGF-­‐1	  can	  ameliorate	  premature	  aging.39	  	  Insulin	  and	  IGF-­‐1	  signaling	  pathways	  is	  linked	  to	  three	  other	  nutrient	  sensing	  pathways.	  mTOR	  signaling	  is	  used	  to	  sense	  high	  amino	  acid	  concentrations.	  AMPK	  and	  Sirtuins	  detect	  low	  energy	  state	  by	  regulating	  the	  levels	  of	  high	  AMP	  and	  NAD+	  levels	  respectively.1	  
1.1.4.2.	  mTOR	  	  The	  mammalian	  target	  of	  rapamycin	  (mTOR)	  signaling	  pathway	  receives	  intracellular	  and	  extracellular	  signals	  to	  regulate	  cellular	  growth,	  proliferation,	  and	  metabolism.40	  mTOR	  pathway	  functions	  in	  many	  cellular	  processes	  including	  but	  not	  limited	  to	  insulin	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resistance	  and	  adipogenesis.40	  In	  type	  2	  diabetes	  and	  cancer,	  mTOR	  signaling	  pathway	  can	  be	  deregulated.	  Rapamycin	  and	  its	  analogues	  are	  currently	  being	  used	  as	  active	  inhibitors	  of	  this	  pathway	  in	  treating	  solid	  tumors,	  organ	  transplantation,	  coronary	  restenosis,	  and	  rheumatoid	  arthritis.40	  mTOR	  kinase	  is	  found	  in	  two	  distinct	  protein	  complexes,	  mTORC1	  and	  mTORC2.1	  Genetically	  modified	  yeast,	  worms,	  and	  flies	  with	  reduced	  expression	  of	  mTORC1	  activity	  were	  shown	  to	  exhibit	  increased	  lifespan,	  mimicking	  the	  similar	  beneficial	  effect	  of	  CR	  on	  lifespan.41	  In	  mice,	  rapamycin	  treatment	  has	  also	  been	  proven	  to	  extend	  lifespan	  through	  the	  inhibitor	  effect	  of	  the	  drug	  on	  the	  mTOR	  signaling	  pathway.42	  Additionally,	  increased	  mTOR	  activity	  in	  mouse	  hypothalamic	  neurons	  caused	  by	  aging	  was	  shown	  to	  promote	  age-­‐associated	  obesity.43	  This	  condition	  can	  be	  reversed	  by	  administering	  rapamycin	  to	  mice	  hypothalamus.43	  Despite	  the	  beneficial	  effects	  of	  mTOR	  inhibition	  on	  extending	  lifespan,	  severe	  side	  effects	  such	  as	  impaired	  wound	  healing,	  insulin	  resistance,	  cataracts,	  and	  testicular	  degeneration	  have	  been	  seen	  in	  mice	  models.44	  	  High	  mTOR	  activity	  together	  with	  IIS	  signaling	  pathways	  can	  accelerate	  aging.	  Opposing	  to	  this	  natural	  phenomenon,	  the	  increased	  activity	  in	  other	  two	  nutrient	  sensors,	  AMPK	  and	  Sirtuins,	  can	  extend	  longevity.	  	  
1.1.4.3.	  AMPK	  	  AMP-­‐activated	  protein	  kinase	  (AMPK)	  plays	  significant	  role	  in	  improving	  lifespan	  by	  regulating	  energy	  homeostasis,	  stress	  resistance,	  and	  cellular	  housekeeping.45	  In	  studies	  that	  were	  conducted	  with	  lower	  organisms,	  upregulation	  of	  AMPK	  activity	  was	  shown	  to	  promote	  longevity.	  In	  mammals,	  AMPK	  acts	  through	  mTOR	  signaling	  to	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reduce	  anabolic	  programs,	  and	  through	  ULK1	  signaling	  to	  control	  autophagy,	  which	  enhances	  the	  quality	  of	  cellular	  housekeeping	  and	  allows	  redistribution	  of	  cellular	  resources.	  AMPK	  activates	  different	  signaling	  pathways	  including	  SIRT-­‐1	  pathway	  to	  improve	  cellular	  stress	  resistance.45	  AMPK	  signaling	  declines	  with	  aging	  and	  its	  beneficial	  effects	  on	  metabolism	  disappear.	  AMPK	  was	  shown	  to	  inhibit	  mTORC1	  activity,	  which	  is	  an	  aging	  enhancing	  protein	  complex	  nucleated	  with	  mTOR	  kinase.46	  AMPK	  also	  possesses	  the	  ability	  to	  activate	  SIRT-­‐1	  in	  a	  manner	  of	  positive	  feedback	  loop47;	  SIRT-­‐1	  activated	  AMPK	  can	  further	  increase	  SIRT-­‐1	  activity	  and	  enable	  SIRT-­‐1	  to	  exhibit	  its	  health-­‐promoting	  effects	  in	  the	  organism.	  Activated	  SIRT-­‐1	  can	  deacetylate	  a	  wide	  range	  of	  target	  proteins	  and	  directly	  or	  indirectly	  stimulate	  many	  different	  signaling	  pathways.	  For	  example,	  SIRT-­‐1	  can	  activate	  PGC-­‐1α,	  a	  key	  molecular	  complex	  that	  control	  metabolic	  responses	  that	  cause	  mitochondriogenesis,	  enhance	  antioxidant	  defenses,	  and	  improve	  fatty	  acid	  oxidation.48	  	  
1.2.	  A	  Summary	  on	  Sirtuin	  1	  and	  Its	  Role	  in	  Metabolism	  
	  Sirtuin	  1	  belongs	  to	  a	  family	  of	  NAD+-­‐	  dependent	  deacetylases.	  These	  enzymes	  function	  as	  cellular	  sensors	  by	  closely	  regulating	  energy	  availability	  and	  accordingly	  modulating	  metabolic	  processes.	  Mammalian	  SIRT1	  protein	  localized	  to	  nucleus	  is	  activated	  upon	  increases	  in	  NAD+/NADH	  ratio,	  which	  is	  an	  indication	  of	  low	  cellular	  energy	  state.49	  Activation	  of	  SIRT1	  causes	  this	  enzyme	  to	  deacetylate	  its	  target	  proteins	  leading	  to	  the	  induction	  of	  catabolic	  processes	  and	  inhibition	  of	  anabolic	  processes.	  Mammalian	  SIRT1	  can	  deacetylate	  proteins,	  which	  possess	  significant	  roles	  in	  apoptosis,	  cell	  cycle,	  circadian	  rhythms,	  mitochondrial	  function,	  and	  metabolism.19	  This	  ability	  of	  SIRT1	  enables	  it	  to	  regulate	  energy	  storage	  and	  in	  turn	  provide	  energy	  homeostasis	  in	  cells	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previously	  experiencing	  deficiency	  in	  energy	  state.	  A	  defect	  in	  any	  of	  SIRT1	  involving	  pathways	  can	  thus	  cause	  the	  disruption	  of	  this	  energy	  balancing	  ability	  of	  the	  gene	  and	  lead	  to	  the	  development	  of	  metabolic	  disorder	  in	  the	  organism.19	  Activation	  of	  SIRT1	  on	  the	  other	  hand	  can	  be	  very	  beneficial	  as	  it	  can	  be	  protective	  against	  many	  diseases	  and	  disorders	  such	  as	  diet-­‐induced	  obesity	  and	  type-­‐2	  diabetes.	  	  	  
	  	  	  	  	  	  	  	  
	  	  










Scheme	  1.	  A	  diagram	  exhibiting	  the	  importance	  of	  SIRT1	  on	  mammalian	  
healthspan.	  Role	  of	  SIRT1	  in	  maintaining	  energy	  balance	  and	  glucose	  homeostasis	  as	  well	  as	  regulating	  cellular	  proliferation	  and	  apoptosis	  in	  mammals	  significantly	  affect	  the	  development	  of	  age-­‐associated	  diseases	  such	  as	  Type-­‐2	  diabetes,	  obesity,	  atherosclerosis,	  and	  intestinal	  cancer.	  Despite	  the	  role	  of	  SIRT1	  in	  prolonging	  mammalian	  lifespan	  has	  not	  yet	  been	  proven,	  part	  of	  its	  impact	  on	  mammalian	  healthspan	  is	  exhibited	  in	  this	  diagram.	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Type	  2	  diabetes.	  SIRT1,	  SIRT3,	  and	  SIRT6	  are	  the	  three	  main	  sirtuin	  genes	  that	  have	  exhibited	  promising	  potential	  as	  drug	  targets	  in	  the	  treatment	  of	  Type	  2	  diabetes.50	  Sirtuin	  activators	  are	  currently	  being	  investigated	  in	  clinical	  trials	  and	  their	  potential	  to	  treat	  Type	  2	  diabetes	  as	  a	  new	  alternative	  approach	  to	  already	  existing	  treatments	  has	  taken	  significant	  attention	  from	  scientific	  communities.	  	  	  	  SIRT1	  is	  the	  most	  studied	  member	  of	  the	  sirtuin	  family.	  SIRT1	  is	  the	  homolog	  of	  Sir2	  gene	  found	  in	  lower	  organisms	  like	  yeast,	  Caenorhabditis	  elegans,	  and	  Drosophila	  
melanogaster.13,	  15,14	  Overexpression	  of	  Sir2	  gene	  in	  these	  organisms	  has	  lead	  to	  the	  extension	  of	  their	  lifespan.13-­‐15	  Considering	  the	  fact	  that	  SIRT1	  is	  the	  mammalian	  homolog	  of	  Sir2,	  scientists	  have	  been	  investigating	  the	  possible	  role	  of	  SIRT1	  in	  extending	  human	  lifespan.	  However,	  the	  life-­‐extending	  effects	  of	  Sir2	  in	  C.	  elegans	  and	  
D.	  melanogaster	  have	  been	  called	  into	  question,	  some	  studies	  presenting	  contradictory	  results	  on	  the	  life-­‐span	  extending	  capability	  of	  Sir2/SIRT1.16	  	  Even	  though	  the	  question	  whether	  SIRT1	  can	  extend	  lifespan	  in	  mammals	  has	  not	  yet	  been	  fully	  answered,	  its	  impact	  on	  age-­‐associated	  diseases,	  like	  Type	  2	  diabetes,	  has	  been	  brought	  into	  light.	  	  
	  
1.4.	  SIRT1	  Expression	  as	  a	  Link	  Between	  Obesity,	  Aging,	  and	  Type-­‐2	  Diabetes	  	  SIRT1	  is	  expressed	  in	  many	  different	  tissues	  such	  as	  liver,	  muscle,	  adipose	  tissue,	  heart,	  pancreas,	  and	  brain.51,	  52	  However,	  expression	  of	  this	  gene	  is	  not	  always	  stable	  as	  it	  can	  go	  down	  with	  increasing	  age	  and	  many	  other	  factors	  can	  play	  into	  the	  expression	  levels	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of	  SIRT1	  in	  different	  tissues.	  For	  example,	  mice	  with	  diet-­‐induced	  obesity	  exhibit	  reduced	  SIRT1	  levels.53	  Humans	  who	  are	  morbidly	  obese	  also	  exhibit	  reduced	  SIRT1	  levels	  in	  visceral	  adipose	  tissue.54	  Mice	  possessing	  moderate	  whole-­‐body	  decrease	  in	  SIRT1	  eventually	  develop	  obesity	  and	  insulin	  resistance55,	  and	  they	  have	  elevated	  lipid	  accumulation	  in	  liver	  and	  inflammation	  in	  adipose	  tissue	  when	  they	  are	  fed	  on	  high-­‐fat	  diet.60	  In	  parallel	  with	  this	  finding,	  mice	  with	  whole	  body	  overexpression	  of	  SIRT1	  are	  leaner	  and	  more	  metabolically	  active,	  eat	  less,	  have	  decreased	  fasting	  serum	  insulin,	  glucose	  and	  cholesterol,	  and	  possess	  improved	  glucose	  tolerance.57	  	  
1.5.	  SIRT1	  can	  be	  Activated	  by	  Resveratrol	  	  The	  role	  of	  Sirtuin	  1	  in	  maintaining	  a	  healthy	  glucose	  and	  lipid	  metabolism	  in	  humans	  have	  lead	  to	  the	  search	  of	  a	  novel	  therapeutic	  drug	  which	  can	  be	  utilized	  to	  activate	  SIRT1	  and	  increase	  its	  expression	  levels	  as	  a	  preventive	  treatment	  method	  against	  Type-­‐2	  diabetes	  and	  other	  aging-­‐associated	  diseases.	  Resveratrol,	  found	  in	  the	  nature	  in	  the	  roots	  of	  white	  hellebore	  plant,	  Veratrum	  grandiflorum,	  has	  been	  widely	  used	  in	  traditional	  Japanese	  and	  Chinese	  medicine	  in	  curing	  hyperlipidemia,	  which	  translates	  into	  high	  cholesterol	  and	  triglyceride	  levels	  in	  blood,	  one	  of	  the	  main	  causative	  factors	  for	  developing	  atherosclerosis.58,	  59	  Hyperlipidemia	  lowering	  effect	  of	  resveratrol	  has	  been	  proven	  scientifically	  since	  resveratrol	  has	  shown	  to	  reduce	  lipid	  accumulation	  in	  rats	  fed	  on	  high-­‐fat	  diet.60	  Resveratrol	  has	  also	  been	  discovered	  in	  red	  wine.61	  This	  discovery	  has	  taken	  significant	  attention	  because	  resveratrol	  could	  be	  the	  answer	  to	  	  the	  French	  paradox,	  which	  arises	  from	  the	  fact	  that	  French	  consume	  high	  amounts	  of	  saturated	  fats	  yet	  they	  exhibit	  one	  of	  the	  lowest	  rates	  of	  cardiovascular	  disease.50	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  Resveratrol	  has	  later	  been	  used	  to	  answer	  one	  of	  the	  most	  intriguing	  questions	  about	  SIRT1:	  Can	  SIRT1	  increase	  lifespan	  upon	  its	  activation	  with	  resveratrol?	  Resveratrol	  has	  yet	  to	  show	  any	  positive	  effect	  on	  increasing	  the	  lifespan	  of	  healthy	  mammals	  under	  normal	  conditions.	  However,	  administration	  of	  this	  drug	  restored	  the	  lifespan	  of	  mice	  fed	  on	  high-­‐calorie	  diet.62	  Resveratrol	  has	  also	  been	  shown	  to	  possess	  many	  antidiabetic	  effects	  in	  rodents.	  By	  activating	  its	  target	  gene	  SIRT1,	  resveratrol	  can	  reduce	  circulating	  glucose	  and	  insulin	  levels,	  improve	  glucose	  tolerance,	  and	  increase	  insulin	  sensitivity.62-­‐65	  Resveratrol	  has	  also	  been	  successful	  in	  reducing	  blood	  glucose	  levels	  in	  rodents	  with	  β-­‐cell	  toxin	  streptozotocin	  induced	  diabetes.66	  Resveratrol	  has	  also	  been	  shown	  to	  reduce	  hepatic	  lipid	  accumulation	  in	  rodents	  fed	  on	  high-­‐calorie	  diets.67	  	  	  Despite	  the	  wide	  use	  of	  resveratrol	  in	  rodents	  in	  diabetes	  and	  lifespan	  context,	  effect	  of	  this	  drug	  and	  its	  potential	  use	  as	  an	  antidiabetic	  and/or	  lifespan	  prolonging	  treatment	  has	  not	  yet	  fully	  explained.	  According	  to	  the	  first	  International	  Conference	  on	  Resveratrol	  and	  Health	  held	  in	  2010,	  scientists	  have	  concluded	  that	  the	  administration	  of	  resveratrol	  to	  humans	  as	  a	  drug	  therapy	  cannot	  yet	  take	  place	  since	  there	  is	  not	  yet	  enough	  scientific	  evidence	  on	  its	  role	  as	  a	  disease	  treating	  drug.68	  In	  the	  studies	  conducted	  by	  Elliott	  et	  al.	  resveratrol	  was	  successful	  in	  decreasing	  fasting	  glucose,	  postprandial	  glucose,	  and	  postprandial	  insulin	  levels	  in	  Type	  2	  diabetic	  patients.69	  In	  a	  study	  done	  by	  Yoshino	  et	  al,	  treating	  non-­‐obese	  women	  with	  normal	  glucose	  tolerance	  with	  75	  mg/day	  resveratrol	  for	  12	  weeks	  exhibited	  no	  effect	  on	  insulin	  sensitivity.70	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Poulsen	  et	  al	  reported	  that	  resveratrol,	  used	  as	  a	  treatment	  method	  on	  obese	  but	  otherwise	  healthy	  men,	  had	  no	  effect	  on	  body	  composition	  and	  insulin	  sensitivity	  of	  the	  subjects.71	  On	  the	  contrary,	  Timmers	  et	  al	  performed	  a	  similar	  study	  where	  resveratrol	  was	  shown	  to	  increase	  intramyocellular	  lipid	  levels	  but	  at	  the	  same	  time	  decrease	  hepatic	  lipids,	  circulating	  glucose,	  insulin,	  leptin,	  and	  improved	  insulin	  sensitivity.72	  	  The	  contradiction	  between	  the	  results	  of	  the	  two	  studies	  mentioned	  above	  might	  have	  arisen	  from	  the	  difference	  in	  study	  designs,	  doses	  of	  resveratrol	  administered,	  and/or	  the	  low	  number	  of	  subjects	  participated	  in	  the	  studies.50	  However,	  it	  is	  definite	  that	  more	  studies	  and	  clinical	  trials	  are	  needed	  before	  resveratrol	  can	  be	  justified	  as	  a	  safe	  and	  efficient	  drug	  treatment	  method	  for	  Type	  2	  diabetes.	  Both	  in	  rodent	  and	  human	  models,	  resveratrol	  has	  minimal	  or	  no	  effect	  on	  glucose	  and	  lipid	  metabolism	  in	  healthy	  subjects.50	  In	  studies	  where	  subjects	  are	  fed	  on	  high-­‐fat	  diet	  it	  has	  been	  shown	  multiple	  times	  that	  resveratrol	  in	  higher	  doses	  has	  more	  potential	  in	  reducing	  body	  weight.50	  However,	  the	  weight	  lowering	  effect	  of	  resveratrol	  in	  high	  doses	  has	  also	  been	  accompanied	  by	  gastrointestinal	  symptoms	  such	  as	  nausea	  and	  diarrhea.73	  In	  general,	  resveratrol	  has	  shown	  promising	  results	  as	  a	  novel	  therapeutic	  antidiabetic	  treatment.	  However,	  it	  still	  requires	  further	  clinical	  studies	  for	  the	  determination	  of	  the	  correct	  dosing	  taking	  into	  account	  its	  pharmacogenetic	  properties.	  The	  indirect	  effects	  of	  resveratrol	  also	  need	  to	  be	  addressed	  in	  clinical	  settings,	  as	  the	  drug	  may	  have	  undesired	  nonspecific	  effects.	  Additionally,	  more	  specific	  SIRT1	  activators	  may	  also	  be	  preferred	  over	  resveratrol	  in	  order	  to	  generate	  better-­‐targeted	  activation	  and	  eliminate	  possible	  unwanted	  side	  effects	  in	  treating	  Type	  2	  diabetes.50	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It	  is	  not	  yet	  clear	  whether	  resveratrol	  directly	  activates	  SIRT1	  or	  its	  impact	  on	  metabolic	  pathways	  indirectly	  cause	  the	  activation	  of	  this	  gene.	  Resveratrol	  was	  reported	  to	  activate	  SIRT1	  in	  vitro	  by	  lowering	  its	  Km	  for	  substrate.74	  In	  a	  study	  performed	  by	  Park	  et	  al,	  resveratrol	  was	  suggested	  to	  activate	  SIRT1	  indirectly	  by	  binding	  to	  phosphodiesterases	  and	  triggering	  cAMP	  signaling,	  causing	  the	  activation	  of	  SIRT1.75	  Other	  studies	  have	  reported	  evidence	  on	  direct	  activation	  of	  SIRT1	  by	  resveratrol.	  Price	  et	  al	  showed	  that	  the	  acute	  deletion	  of	  SIRT1	  in	  adult	  mice	  inhibited	  the	  physiological	  effects	  of	  resveratrol,	  which	  indicates	  that	  these	  effects	  are	  mediated	  through	  SIRT1	  protein	  activity.47	  In	  addition,	  single	  point	  mutation	  in	  SIRT1	  gene	  was	  found	  to	  destroy	  the	  SIRT1	  activating	  ability	  of	  resveratrol	  as	  well	  as	  of	  all	  other	  117	  synthetic	  SIRT1	  activating	  compounds	  (STACs).76	  This	  point	  mutation	  has	  most	  probably	  altered	  the	  structure	  of	  the	  allosteric	  site	  of	  SIRT1	  enzyme,	  which	  inhibited	  the	  binding	  of	  the	  enzyme	  to	  its	  activators	  such	  as	  resveratrol.	  	  
1.6.	  Effect	  of	  Calorie	  Restriction	  on	  SIRT1	  Activity	  and	  Aging	  	  Calorie	  or	  dietary	  restriction	  (CR)	  has	  been	  shown	  to	  extend	  life	  span	  in	  rodent	  models.77	  This	  effect	  of	  CR	  on	  aging	  of	  organisms	  is	  believed	  to	  be	  mediated	  by	  the	  nutrient	  sensor	  genes,	  the	  sirtuins.	  Calorie	  restriction	  activates	  sirtuins,	  including	  SIRT1,	  and	  leads	  to	  its	  health	  promoting	  outcomes	  as	  stated	  in	  previous	  chapters.	  Resveratrol	  is	  at	  the	  center	  of	  scientific	  attention	  and	  currently	  being	  investigated	  in	  clinical	  trials	  as	  a	  drug	  that	  mimics	  the	  sirtuin	  activator	  effect	  of	  CR.	  	  In	  previous	  studies,	  CR	  in	  the	  form	  of	  30-­‐40%	  reduction	  in	  the	  ad	  libitum	  levels	  of	  chow	  intake	  was	  shown	  to	  extend	  lifespan	  in	  rodents.78	  In	  yeast,	  reducing	  glucose	  supply	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from	  2%	  to	  0.5%	  was	  also	  found	  to	  be	  increasing	  the	  replicative	  lifespan	  of	  the	  organism.79	  However,	  this	  extension	  in	  lifespan	  vanishes	  when	  SIR2	  is	  knocked	  out	  from	  yeast	  genome79,	  which	  is	  a	  significant	  indication	  of	  the	  role	  of	  SIRT1	  homolog	  SIR2	  in	  aging	  of	  the	  organism.	  SIR2	  independent	  lifespan	  extension	  pathways	  have	  also	  been	  discovered	  in	  yeast	  models	  in	  situations	  where	  limitations	  in	  glucose	  level	  supply	  was	  much	  more	  severe.80	  	  	  CR	  studies	  using	  mice	  models	  are	  preferred	  over	  similar	  studies	  including	  lower	  organisms	  as	  the	  dietary	  restriction	  can	  be	  more	  standardized.77	  In	  most	  of	  the	  experiments,	  C57BL/6	  mice	  are	  fed	  with	  30%	  reduction	  of	  the	  ad	  libitum	  consumption	  of	  chow	  food.77	  In	  these	  studies,	  CR	  activates	  sirtuins-­‐	  predominantly	  SIRT1-­‐	  and	  increases	  their	  expression	  levels.	  When	  mice	  are	  fed	  with	  diet	  rich	  in	  fat,	  SIRT1	  function	  is	  lost	  in	  mice.81	  Obesity	  has	  the	  similar	  effect	  in	  humans,	  where	  SIRT1	  function	  and	  expression	  levels	  can	  go	  down	  in	  visceral	  adipose	  tissue	  especially	  in	  morbidly	  obese	  individuals.82	  Genetic	  modifications	  in	  SIRT1	  also	  alter	  the	  effect	  of	  CR	  in	  rodents.	  For	  example,	  knocking	  out	  SIRT1	  in	  mice	  prevents	  the	  improvement	  in	  physical	  activity	  mediated	  by	  CR.83	  Transgenic	  overexpression	  of	  this	  gene	  also	  mimics	  the	  health	  promoting	  benefits	  of	  CR.	  Overexpression	  of	  SIRT1	  was	  shown	  to	  alleviate	  the	  health	  condition	  of	  mice	  with	  diabetes,	  neurodegenerative	  diseases,	  liver	  steatosis,	  bone	  loss,	  and	  inflammation.62,	  84,	  57,	  85,	  17,	  86	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1.7.	  Mammalian	  Intestinal	  Epithelium	  and	  Organoid	  Biology	  	  Intestinal	  epithelium	  is	  composed	  of	  a	  single-­‐cell	  layer	  consisting	  of	  two	  main	  structures:	  crypts	  and	  villi.87	  Intestinal	  stem	  cells	  (ISC)	  are	  located	  in	  crypts,	  more	  specifically	  at	  the	  crypt	  bottoms.104	  These	  stem	  cells	  function	  as	  progenitors	  for	  intestinal	  secretory	  and	  absorptive	  cells.	  ISCs	  are	  positive	  for	  Leucine-­‐rich	  repeat-­‐containing	  G-­‐protein	  coupled	  receptor	  5	  (Lgr5+	  cells)	  and	  divide	  approximately	  once	  in	  24	  hours.	  Their	  progeny	  will	  continue	  dividing	  for	  few	  divisions	  and	  form	  the	  so-­‐called	  Transient	  Amplifying	  pool	  of	  cells	  (TA	  cells).	  Simultaneously	  to	  cell	  divisions,	  the	  TA	  cells	  will	  progressively	  differentiate	  into	  mature	  cells	  of	  intestinal	  epithelium	  as	  they	  migrate	  upwards	  along	  the	  crypt-­‐villus	  axis,	  and	  will	  stop	  dividing.	  Well-­‐controlled	  differentiation	  is	  necessary	  for	  intestinal	  functions	  such	  as	  the	  maintenance	  of	  microbial	  barrier	  by	  mucus	  and	  defensin	  secretion,	  and	  for	  absorption	  of	  water	  and	  nutrients.88	  Lgr5+	  intestinal	  stem	  cells	  are	  located	  between	  Paneth	  cells	  in	  intestinal	  epithelium.	  Paneth	  cells	  provide	  the	  specific	  niche	  conditions	  that	  are	  required	  for	  the	  viability	  and	  self-­‐renewal	  of	  ISCs.105	  Paneth	  cells	  also	  input	  biological	  signals	  to	  ISCs,	  which	  keep	  the	  latter	  in	  the	  stem-­‐like	  state	  and	  inhibit	  undesired	  differentiation.87	  	  Lgr5+	  stem	  cells	  can	  be	  isolated	  from	  the	  small	  intestine	  of	  mice	  either	  as	  single	  cells	  or	  as	  part	  of	  intestinal	  crypts.	  When	  cultured	  in	  vitro,	  these	  cells	  form	  organoids,	  which	  are	  living	  forms	  that	  possess	  an	  intact	  lumen	  in	  the	  form	  of	  crypt-­‐villi	  units.103	  	  Organoids	  can	  grow	  in	  vitro	  with	  continuous	  division	  and	  differentiation	  of	  Lgr5+	  ISCs	  into	  mature	  cells	  of	  intestinal	  epithelium.87	  Intestinal	  crypts	  isolated	  from	  small	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intestine	  of	  mice	  can	  be	  embedded	  in	  Matrigel	  and	  cultured	  in	  the	  presence	  of	  epidermal	  growth	  factor	  (EGF),	  R-­‐Spondin,	  Noggin,	  N2,	  NAC,	  and	  B27	  molecules	  diluted	  in	  DMEM/F12	  media	  containing	  Glutamax.	  These	  organoid	  growth-­‐promoting	  factors,	  collectively	  known	  as	  ENR,	  provide	  the	  cues	  necessary	  for	  organoid	  development	  but	  they	  are	  not	  sufficient	  in	  promoting	  the	  stem-­‐like	  state	  of	  Lgr5+	  ISCs	  because	  the	  self-­‐renewal	  and	  differentiation	  of	  Lgr5+	  ISCs	  is	  dependent	  on	  direct	  contact	  with	  Paneth	  cells.87	  Lgr5+	  cells	  cannot	  be	  cultured	  in	  vitro	  without	  the	  presence	  of	  Paneth	  cells,	  as	  the	  former	  immediately	  differentiate	  into	  cells	  of	  intestinal	  epithelium.	  Self-­‐renewal	  and	  differentiation	  of	  Lgr5+	  stem	  cells	  are	  controlled	  mainly	  by	  Wnt,	  Notch,	  and	  bone	  morphogenetic	  protein	  (BMP)	  pathways.87	  In	  a	  previous	  study,	  two	  molecules	  that	  target	  these	  pathways	  in	  single	  Lgr5+	  stem	  cells	  and	  intestinal	  organoids	  and	  maintain	  the	  stem-­‐like	  state	  of	  Lgr5+	  stem	  cells	  were	  identified.87	  These	  two	  compounds,	  CHIR	  and	  Valproic	  Acid,	  have	  enabled	  scientists	  to	  control	  the	  differentiation	  of	  the	  stem	  cells	  and	  eliminate	  the	  effective	  role	  of	  Paneth	  cells	  in	  this	  phenomenon.	  
1.8.	  Wnt	  Signaling,	  SIRT1,	  Intestines,	  “Stemness”,	  and	  Cancer	  	  
1.8.1.	  Wnt	  Signaling	  and	  SIRT1	  	  Wnt	  signaling	  regulates	  adipogenesis,	  tumorigenesis,	  and	  stem	  cell	  pluripotency.89	  Wnt	  ligands	  transmit	  signals	  by	  activating	  Frizzled	  receptors,	  complex	  receptors	  that	  cross	  the	  plasma	  membrane	  multiple	  times.89	  Activation	  of	  this	  set	  of	  receptors	  enables	  signal	  propagation	  inside	  the	  cells	  with	  the	  help	  of	  Dishevelled	  proteins	  and	  β-­‐catenin	  molecules	  in	  a	  downstream	  manner.	  β-­‐catenin-­‐dependent	  signaling	  in	  which	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Dishevelled	  proteins	  transfer	  the	  signal	  from	  Wnt	  ligands	  to	  β-­‐catenin	  molecules	  is	  called	  canonical	  signaling.89	  	  	  In	  the	  absence	  of	  Wnt	  signaling,	  glycogen	  synthase	  kinase-­‐	  3β	  (GSK-­‐3β)	  phosphorylates	  several	  proteins	  that	  favor	  cellular	  proliferation,	  including	  β-­‐catenin,	  tagging	  them	  for	  destruction.90	  In	  the	  presence	  of	  Wnt	  ligands,	  activation	  of	  Frizzled	  receptors	  initiate	  an	  intracellular	  signaling	  cascade	  that	  inhibit	  GSK-­‐3β	  activity	  and	  indirectly	  permitting	  growth-­‐	  promoting	  proteins	  to	  stimulate	  cellular	  growth.90	  	  SIRT1,	  NAD+-­‐dependent	  deacetylase,	  was	  previously	  shown	  to	  control	  this	  Wnt	  signaling	  pathway	  by	  directly	  regulating	  Dishevelled	  protein	  levels.89	  SIRT1	  loss	  of	  function	  was	  shown	  to	  reduce	  intracellular	  levels	  of	  Dishevelled	  proteins.89	  Inhibiting	  SIRT1	  function	  was	  also	  demonstrated	  as	  a	  blockade	  against	  Wnt-­‐stimulated	  cell	  migration.89	  	  	  
1.8.2.	  Wnt	  Signaling	  and	  APC	  gene	  in	  Intestines	  	  Another	  regulator	  of	  Wnt	  signaling	  pathway	  is	  the	  product	  of	  the	  Adenomatous	  polyposis	  coli	  –gene	  (APC).90	  APC	  controls	  cellular	  proliferation	  in	  the	  whole	  intestine.	  Induced	  by	  high	  level	  of	  Wnt	  signals	  at	  the	  crypt	  bottom,	  intracellular	  β-­‐catenin	  promotes	  the	  self-­‐renewal	  and	  “stemness”	  of	  intestinal	  stem	  cells.90	  As	  the	  ISCs	  divide,	  their	  previously	  produced	  progeny	  is	  pushed	  upwards	  within	  the	  crypt.90	  Cells	  higher	  up	  in	  the	  crypt	  do	  not	  receive	  as	  many	  Wnt	  signals	  as	  at	  the	  crypt	  bottom,	  and	  intracellular	  β-­‐catenin	  levels	  fall	  steeply.	  As	  a	  result,	  these	  cells	  lose	  their	  stem	  cell	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phenotype,	  exit	  the	  cell	  cycle,	  and	  differentiate	  into	  functional	  intestinal	  cells	  of	  either	  the	  secretory	  or	  absorptive	  lineage.90	  	  APC	  is	  a	  gene	  that	  negatively	  controls	  intracellular	  β-­‐catenin	  levels	  in	  intestinal	  epithelial	  cells.90	  APC	  gene	  is	  expressed	  in	  undetectable	  levels	  in	  the	  cells	  located	  at	  crypt	  bottoms,	  which	  also	  leads	  to	  high	  intracellular	  β-­‐catenin	  levels	  inside	  the	  intestinal	  stem	  cells.90	  If	  Wnt	  ligands	  are	  absent,	  reduction	  in	  β-­‐catenin	  levels	  increases	  even	  more	  leading	  to	  the	  cellular	  differentiation	  of	  the	  stem	  cells	  into	  mature	  cells	  of	  intestinal	  epithelium.90	  	  	  
1.8.3.	  Link	  between	  SIRT1,	  APC,	  Wnt	  Signaling,	  and	  Intestinal	  Cancer	  	  Over-­‐activation	  of	  Wnt	  signaling	  pathway	  in	  intestines	  has	  been	  linked	  to	  the	  development	  of	  colon	  cancer.91	  This	  over-­‐activation	  might	  cause	  the	  formation	  of	  benign	  tumors	  in	  the	  beginning.	  Accumulation	  of	  additional	  genetic	  damage,	  which	  may	  arise	  due	  to	  aging,	  advances	  benign	  intestinal	  polyps	  into	  malignant	  tumors.91	  SIRT1	  has	  been	  identified	  as	  a	  target	  gene	  that	  plays	  a	  key	  role	  in	  tumor	  formation	  in	  intestines.92	  In	  previous	  research,	  SIRT1	  has	  exhibited	  both	  tumor-­‐suppressive	  and	  tumor-­‐promoting	  roles	  in	  intestines	  of	  mice	  models.93,	  94	  Global	  deletion	  of	  SIRT1	  in	  APC+/min	  mice	  was	  shown	  to	  assign	  a	  tumor-­‐promoting	  role	  for	  SIRT1;	  whereas	  enterocyte-­‐specific	  overexpression	  of	  SIRT1	  led	  to	  the	  conclusion	  that	  SIRT1	  was	  a	  tumor-­‐suppressive	  gene.92	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Leko	  et	  al,	  tried	  to	  find	  an	  explanation	  to	  this	  contradiction.	  APC+/min	  mice	  were	  crossed	  with	  mice	  possessing	  enterocyte-­‐specific	  inactivation	  of	  SIRT1	  to	  observe	  intestinal	  polyp	  formation	  in	  the	  offsprings.	  APC+/min	  mice	  demonstrate	  primary	  phases	  of	  colon	  cancer	  in	  humans	  and	  this	  model	  is	  widely	  preferred	  to	  study	  the	  impact	  of	  candidate	  tumor	  suppressor	  genes	  and	  oncogenes	  on	  the	  development	  of	  intestinal	  tumors.95	  Heterozygous	  APC+/min	  mice	  inherit	  a	  nonsense	  mutation	  in	  one	  allele	  of	  APC	  and	  later	  lose	  the	  wild	  type	  allele	  after	  birth,	  leading	  to	  the	  constitutive	  activation	  of	  Wnt-­‐signaling	  pathway	  element	  β-­‐catenin	  and	  the	  formation	  of	  multiple	  intestinal	  polyps.96,	  
97	  Overexpression	  of	  SIRT1	  only	  in	  the	  intestinal	  epithelium	  of	  APC+/min	  mice	  resulted	  in	  the	  formation	  of	  fewer	  intestinal	  polyps,	  which	  was	  explained	  as	  increased	  deacetylation	  and	  nuclear	  exclusion	  of	  β-­‐catenin.98	  However,	  since	  overexpressing	  SIRT1	  to	  levels	  that	  are	  several	  fold	  higher	  than	  normal	  physiological	  levels	  can	  mimic	  gene	  loss-­‐of-­‐function,	  the	  effect	  of	  SIRT1	  deficiency	  on	  polyp	  formation	  in	  APC+/min	  mice	  was	  also	  studied.92	  APC+/min	  mice	  with	  global	  SIRT1	  deletion	  developed	  similar	  numbers	  of	  polyps	  as	  APC+/min	  mice	  controls.99	  However,	  mice	  with	  global	  deletion	  of	  SIRT1	  also	  exhibited	  smaller	  polyps,	  which	  indicates	  that	  SIRT1	  may	  actually	  be	  a	  tumor	  promoter.99	  Furthermore,	  mice	  with	  global	  SIRT1	  deletion	  were	  shown	  to	  express	  severe	  growth	  retardation	  and	  reduced	  blood	  levels	  of	  free	  Insulin-­‐like	  Growth	  Factor	  I	  (IGF-­‐I),	  which	  is	  a	  molecule	  known	  for	  its	  tumor-­‐promoting	  ability.99	  Thus,	  smaller	  intestinal	  polyps	  might	  be	  the	  result	  of	  severe	  reduction	  in	  the	  blood	  levels	  of	  tumor	  enhancer	  IGF-­‐I	  protein	  not	  SIRT1.	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To	  study	  the	  true	  effect	  of	  SIRT1	  deficiency	  in	  intestinal	  polyp	  formation	  and	  resolve	  the	  contradicting	  results	  previously	  reported	  on	  the	  role	  of	  SIRT1	  in	  tumor	  development,	  Leko	  et	  al	  restricted	  SIRT1	  inactivation	  to	  intestinal	  epithelium.92	  In	  this	  study,	  SIRT1	  inactivation	  reduced	  the	  total	  polyp	  surface,	  average	  polyp	  size,	  and	  the	  number	  of	  polyps.92	  SIRT1	  inactivation	  has	  also	  caused	  significant	  increases	  in	  the	  number	  of	  cells	  experiencing	  apoptosis,	  which	  indicates	  that	  SIRT1	  functions	  as	  a	  tumor-­‐enhancing	  gene,	  promoting	  the	  survival	  of	  tumor	  cells	  in	  mice	  intestines.92	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2.	  Aim	  of	  the	  Study	  	  The	  objective	  of	  this	  study	  is	  to	  address	  if	  the	  Sirtuin	  1	  has	  a	  role	  in	  homeostatic	  intestinal	  stem	  cell	  maintenance,	  and	  if	  the	  Sirtuin	  1	  activity	  specifically	  in	  the	  Paneth	  cells	  or	  intestinal	  stem	  cells	  is	  required	  for	  the	  maintenance	  of	  intestinal	  epithelium.	  This	  objective	  will	  be	  addressed	  by	  utilizing	  mouse	  intestinal	  organoid	  models,	  which	  form	  in	  vitro	  from	  isolated	  crypts	  of	  mouse	  intestinal	  epithelium.	  	  Furthermore,	  the	  link	  between	  Sirtuin	  1	  and	  crypt	  growth	  will	  be	  investigated	  to	  observe	  if	  targeting	  the	  Sirtuin	  1	  could	  present	  a	  novel	  strategy	  to	  alter	  intestinal	  regeneration.	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3.	  Materials	  and	  Methods	  
	  
3.1.	  Preparation	  of	  Glycogen	  Stocks	  	  Bacterial	  inoculates	  with	  five	  types	  of	  plasmids	  necessary	  for	  SIRT-­‐1	  gene	  targeting	  grown	  in	  Carbenicillin/	  Terrific	  Broth	  media	  were	  used	  to	  prepare	  glycogen	  stocks.	  100-­‐μL	  of	  bacterial	  solution	  was	  combined	  with	  900-­‐μL	  of	  glycogen	  for	  each	  sample	  and	  the	  mixture	  was	  then	  stored	  at	  -­‐80	  °C.	  	  	  
3.2.	  Purification	  of	  Plasmids	  of	  Interest	  	  1-­‐mL	  of	  each	  bacterial	  inoculate	  was	  then	  transferred	  into	  250-­‐mL	  of	  100	  μg/mL	  Carbenicillin	  in	  TB	  media.	  The	  solutions	  were	  placed	  in	  a	  mechanical	  mixer	  and	  mixed	  overnight	  at	  37	  °C	  at	  220	  rpm.	  The	  next	  day	  solutions	  were	  cloudy,	  which	  indicated	  that	  the	  bacteria	  were	  able	  to	  grow	  in	  Carbenicillin	  /TB	  media.	  Each	  mixture	  was	  then	  super-­‐centrifuged	  at	  10,000g	  for	  10	  minutes	  at	  4	  °C	  in	  order	  to	  obtain	  bacterial	  pellets.	  	  	  Plasmids	  were	  purified	  from	  bacterial	  pellets	  by	  using	  the	  NucleoBond®	  Xtra	  Plasmid	  Purification	  kit	  from	  Macherey-­‐Nagel	  (MN).	  The	  bacterial	  pellets	  were	  first	  suspended	  in	  12-­‐mL	  of	  resuspension	  buffer	  by	  pipetting	  the	  cells	  up	  and	  down.	  12-­‐mL	  of	  lysis	  buffer	  was	  then	  added	  and	  the	  solution	  was	  mixed	  gently	  by	  inverting	  the	  tube	  5	  times.	  The	  mixture	  was	  then	  incubated	  at	  room	  temperature	  for	  5	  minutes.	  12-­‐mL	  of	  neutralization	  buffer	  was	  added	  to	  the	  suspension	  and	  the	  lysate	  was	  mixed	  gently	  by	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inverting	  it	  10	  times	  until	  the	  color	  turned	  from	  dark	  blue	  to	  cloudy	  white.	  Neutralization	  at	  the	  proper	  time	  is	  very	  important	  because	  prolonged	  exposure	  to	  the	  lysis	  buffer	  can	  denature	  and	  degrade	  the	  plasmid	  DNA	  and	  also	  release	  contaminating	  chromosomal	  DNA	  into	  the	  lysate.100	  Next	  step	  was	  equilibrating	  a	  NucleoBond®	  Xtra	  Column	  together	  with	  an	  inserted	  column	  filter.	  The	  column	  was	  first	  placed	  under	  a	  falcon	  tube	  and	  the	  filter	  was	  equilibrated	  with	  25-­‐mL	  of	  equilibration	  buffer.	  The	  buffer	  was	  applied	  to	  the	  rim	  of	  the	  filter	  and	  column	  was	  allowed	  to	  empty	  by	  gravity.	  	  	  The	  precipitate	  formed	  after	  adding	  the	  neutralization	  buffer	  was	  removed	  by	  centrifugation	  at	  10,000g	  for	  10	  minutes.	  It	  is	  very	  important	  to	  remove	  the	  precipitate	  properly	  since	  it	  can	  clog	  the	  column	  filter	  during	  the	  filtration	  and	  reduce	  the	  plasmid	  yield.100	  The	  lysate	  cleared	  from	  the	  precipitate	  was	  applied	  to	  the	  rim	  of	  the	  column	  filter	  and	  allowed	  to	  empty	  by	  gravity.	  NucleoBond®	  Xtra	  Column	  was	  then	  washed	  with	  15-­‐mL	  of	  equilibration	  buffer	  in	  order	  to	  wash	  out	  the	  lysate	  remaining	  in	  the	  filter.	  The	  column	  filter	  was	  discarded	  and	  the	  column	  was	  washed	  with	  25-­‐mL	  of	  wash	  buffer.	  Next	  step	  in	  purification	  was	  to	  elute	  the	  plasmid	  DNA	  via	  15-­‐mL	  of	  elution	  buffer.	  The	  eluate	  was	  collected	  and	  10.5-­‐mL	  of	  room	  temperature	  isopropanol	  was	  added	  to	  the	  eluate	  plasmid	  DNA	  for	  precipitation.	  The	  mixture	  was	  first	  vortexed	  and	  then	  centrifuged	  at	  15,000g	  for	  30	  minutes	  at	  4	  °C.	  After	  the	  centrifugation	  the	  plasmid	  precipitated	  to	  the	  bottom	  of	  the	  tube	  and	  the	  supernatant	  was	  carefully	  discarded.	  The	  obtained	  five	  DNA	  pellets	  were	  washed	  with	  5-­‐mL	  of	  room	  temperature	  70%	  ethanol.	  DNA	  pellets	  washed	  with	  ethanol	  were	  then	  centrifuged	  at	  15,000g	  for	  5	  minutes	  at	  room	  temperature.	  Ethanol	  was	  then	  removed	  completely	  from	  the	  tube	  with	  a	  pipette	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and	  the	  pellets	  were	  let	  to	  dry	  at	  room	  temperature	  for	  10-­‐15	  minutes.	  DNA	  pellets	  were	  then	  dissolved	  in	  1-­‐mL	  of	  TE	  buffer	  by	  pipetting	  up	  and	  down.	  Plasmid	  concentrations	  were	  determined	  by	  using	  a	  NanoDrop	  Spectrophotometer.	  	  	  
3.3.	  Agarose	  Gel	  Electrophoresis	  of	  Plasmid	  DNA	  
	  1%	  Agarose	  gel	  was	  prepared	  by	  adding	  1.5g	  of	  solid	  agarose	  into	  150-­‐mL	  of	  1x	  Borate	  buffer.	  The	  mixture	  was	  microwaved	  until	  solution	  started	  to	  boil.	  Mixture	  was	  then	  cooled	  down	  under	  cold	  water	  and	  placed	  on	  the	  bench	  for	  further	  cooling.	  Meanwhile,	  gel	  electrophoresis	  casting	  pieces	  were	  set	  and	  placed	  under	  the	  fume	  hood.	  3	  drops	  of	  Ethylium	  Bromide	  (EB)	  were	  added	  into	  the	  solution	  under	  the	  fume	  hood	  upon	  the	  cooling	  of	  the	  solution	  and	  the	  solution	  was	  swirled	  and	  mixed	  well.	  Solution	  was	  then	  poured	  into	  the	  electrophoresis	  cast	  and	  let	  for	  solidification	  for	  30	  minutes.	  After	  the	  gel	  was	  solidified,	  the	  comb	  was	  removed	  and	  the	  gel	  was	  placed	  in	  the	  electrophoresis	  machine	  already	  filled	  with	  1x	  Borate	  buffer.	  8-­‐μL	  of	  1.5kB	  DNA	  ladder	  was	  carefully	  pipetted	  into	  the	  first	  well	  from	  the	  left.	  1-­‐μg	  of	  each	  plasmid	  purified	  previously	  was	  combined	  with	  5-­‐μL	  of	  6x	  loading	  dye	  and	  mixtures	  were	  loaded	  into	  the	  gel	  wells.	  The	  machine	  cables	  were	  connected	  properly	  and	  device	  was	  set	  to	  running	  at	  120	  V	  for	  1	  hour	  at	  room	  temperature.	  After	  the	  running	  was	  complete,	  gel	  was	  imaged	  for	  plasmid	  bands.	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3.4.	  Packaging	  of	  Lentivirus/	  Transfection	  of	  HEK	  293Ts	  
	  In	  Day	  1,	  HEK-­‐293T	  cells	  grown	  in	  regular	  DMEM	  media-­‐1%	  penicillin-­‐streptomycin	  (P/S)	  in	  10-­‐cm	  dish	  were	  passaged	  in	  a	  way	  that	  they	  were	  70%	  confluent	  the	  next	  day.	  In	  Day	  2,	  750-­‐μL	  of	  OPTI-­‐MEM	  media	  were	  mixed	  with	  750-­‐ng	  VSVG	  plasmid,	  6.750-­‐μg	  del-­‐8.9	  plasmid,	  and	  7.5-­‐μg	  of	  one	  of	  the	  plasmids	  of	  interest	  purified	  by	  using	  the	  MN	  MaxiPrep	  Kit.	  	  This	  step	  was	  repeated	  six	  times	  for	  each	  plasmid	  of	  interest.	  In	  another	  tube,	  4.5-­‐mL	  of	  OPTI-­‐MEM	  was	  mixed	  with	  180-­‐μL	  of	  lipofectamine	  2000	  and	  the	  mixture	  was	  incubated	  at	  room	  temperature	  for	  5	  minutes.	  750-­‐μL	  of	  OPTI-­‐MEM+lipofectamine	  2000	  mixture	  was	  mixed	  with	  750-­‐μL	  plasmid	  mixture.	  This	  step	  was	  also	  repeated	  six	  times	  in	  order	  to	  make	  separate	  mixture	  for	  each	  plasmid	  with	  lipofectamine	  2000.	  1.5-­‐mL	  of	  mixture	  was	  then	  mixed	  gently	  and	  incubated	  at	  room	  temperature	  for	  20	  minutes.	  1.5-­‐mL	  of	  the	  OPTI-­‐MEM,	  lipofectamine	  2000,	  and	  plasmids	  solution	  was	  added	  to	  6-­‐ml	  of	  DMEM	  without	  P/S.	  This	  mixture	  was	  replaced	  with	  the	  old	  media	  of	  HEK	  293T	  cells.	  The	  new	  mixture	  was	  added	  dropwise	  with	  a	  1-­‐mL	  pipette	  onto	  the	  cells.	  The	  cells	  were	  kept	  in	  an	  incubator	  for	  48	  hours	  with	  no	  change	  of	  media.	  	  	  In	  Day	  4,	  supernatants	  were	  collected	  from	  each	  10-­‐cm	  dish	  and	  were	  passed	  through	  a	  45-­‐μm	  filter	  to	  get	  rid	  of	  the	  cell	  debris.	  Six	  types	  of	  supernatants	  each	  containing	  a	  different	  lentivirus	  were	  then	  concentrated	  by	  using	  Lenti-­‐X™	  Concentrator	  from	  Clontech.	  1	  volume	  of	  Lenti-­‐X™	  Concentrator	  was	  combined	  with	  3	  volumes	  of	  viral	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supernatant.	  The	  solution	  was	  mixed	  gently	  by	  inversion	  and	  was	  incubated	  at	  4	  °C	  overnight.	  Next	  day	  samples	  were	  centrifuged	  at	  1,500g	  for	  45	  minutes	  at	  4	  °C.	  An	  off-­‐white	  pellet	  was	  visible	  after	  the	  centrifugation.	  The	  supernatant	  was	  removed	  and	  the	  pellet	  was	  resuspended	  in	  total	  volume	  of	  70-­‐μL,	  which	  included	  pellet	  residual	  volume	  and	  DMEM.	  The	  concentrated	  viral	  samples	  were	  stored	  at	  -­‐80	  °C	  to	  be	  used	  for	  cell	  infection	  in	  the	  following	  day.	  
3.5.	  Transduction	  and	  Selection	  of	  NIH	  3T3	  Cells	  with	  Lentivirus	  	  In	  Day	  1,	  10-­‐cm	  plate	  of	  mouse	  fibroblast	  NIH	  3T3	  cells	  were	  passaged	  into	  two	  6-­‐well	  plates	  in	  a	  way	  that	  they	  were	  70%	  confluent	  the	  next	  day.	  A	  mixture	  of	  DMEM	  media	  with	  P/S,	  8-­‐μg/mL	  polybrene,	  and	  5-­‐μL	  of	  one	  of	  six	  concentrated	  lentiviruses	  was	  prepared.	  The	  solution	  was	  mixed	  gently	  by	  inversion	  and	  was	  used	  to	  replace	  the	  old	  DMEM	  media	  with	  P/S.	  The	  plates	  were	  kept	  in	  the	  incubator	  for	  two	  days.	  In	  Day	  3,	  old	  media	  was	  replaced	  with	  DMEM	  media	  with	  P/S	  having	  1.5-­‐μg/mL	  puromycin,	  the	  antibiotic	  for	  selecting	  the	  infected	  cells.	  Media	  with	  puromycin	  was	  kept	  on	  the	  cells	  for	  two	  days.	  In	  Day	  5,	  puromycin	  media	  was	  replaced	  with	  basic	  DMEM	  media	  with	  P/S.	  	  In	  Day	  6,	  each	  type	  of	  infected	  and	  selected	  NIH	  3T3	  cells	  from	  one	  of	  two	  wells	  was	  lysed	  for	  protein	  quantification	  and	  western	  blotting.	  
3.6.	  Sample	  Preparation	  for	  Western	  Blotting	  	  NIH	  3T3	  cells	  recovered	  from	  puromycin	  selection	  were	  lysed	  for	  Western	  Blot	  analysis.	  First,	  old	  regular	  media	  was	  aspirated	  and	  the	  cells	  were	  washed	  with	  ice-­‐cold	  PBS.	  	  500-­‐μL	  of	  RIPA	  buffer	  with	  2x	  protease	  and	  phosphatase	  inhibitors	  were	  added	  on	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the	  cells.	  Cell	  scraper	  was	  used	  to	  collect	  the	  lysate	  into	  1.5-­‐μL	  centrifuge	  tubes.	  Cells	  were	  kept	  on	  ice	  during	  the	  whole	  process.	  	  After	  the	  lysates	  were	  collected,	  samples	  were	  agitated	  in	  the	  cold	  room	  for	  30	  minutes,	  which	  was	  followed	  by	  spinning	  down	  at	  16,000	  g	  at	  4	  °C	  to	  get	  rid	  of	  the	  cell	  debris.	  Supernatants	  were	  then	  transferred	  into	  new	  eppendorf	  tubes	  and	  the	  pellets	  were	  discarded.	  	  	  Absorbance	  measurement	  was	  done	  in	  order	  to	  determine	  the	  protein	  concentration	  of	  the	  lysate	  samples.	  BSA	  (Bovine	  serum	  albumin)	  standard	  protein	  assay	  was	  used	  and	  BSA	  dilutions	  of	  1	  mg/mL,	  0.5	  mg/mL,	  0.25	  mg/mL,	  0.125	  mg/mL,	  0.06	  mg/mL,	  and	  0	  mg/mL	  were	  prepared.	  Both	  the	  sample	  and	  the	  standard	  were	  diluted	  with	  the	  lysis	  buffer.	  25-­‐μL	  of	  sample	  and	  standard	  were	  added	  to	  the	  plate	  for	  absorbance	  measurement	  and	  covered	  with	  aluminum	  foil.	  Samples	  were	  kept	  at	  37	  °C	  for	  1	  hour	  and	  then	  taken	  to	  absorbance	  reader	  machine.	  Absorbance	  values	  and	  BSA-­‐standard	  linear	  curve	  were	  then	  used	  to	  calculate	  the	  protein	  concentration	  in	  the	  lysate	  samples.	  Concentration	  values	  were	  used	  to	  calculate	  the	  amount	  of	  protein	  to	  load	  for	  Western	  Blotting	  analysis.	  	  
3.7.	  Western	  Blotting	  with	  NIH	  3T3	  Cell	  Lysates	  	  Total	  volume	  of	  40-­‐μL	  of	  protein	  from	  lysed	  NIH	  3T3	  cells,	  10x	  reducing	  agent,	  4x	  sample	  buffer,	  and	  water	  were	  prepared	  and	  mixed	  gently	  by	  pipetting	  up	  and	  down	  in	  the	  cold	  room.	  Heat	  block	  was	  switched	  on	  and	  temperature	  was	  set	  to	  70	  °C.	  Samples	  were	  incubated	  at	  70	  °C	  for	  10	  minutes	  and	  were	  put	  back	  on	  the	  ice	  immediately	  after	  incubation.	  Samples	  were	  centrifuged	  down	  briefly	  and	  placed	  back	  on	  ice.	  A	  Western	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Blotting	  tank	  was	  filled	  with	  appropriate	  volume	  of	  1x	  MES-­‐running	  buffer	  and	  the	  machine	  was	  set	  for	  running	  according	  to	  the	  user	  guidelines.	  	  40-­‐μL	  of	  each	  sample	  was	  loaded	  into	  the	  wells	  and	  the	  sample	  was	  run	  at	  165	  V	  for	  35	  minutes.	  In	  between	  the	  sample	  running,	  two	  sponges	  were	  soaked	  in	  the	  transfer	  buffer.	  Two	  PVDF	  membranes	  were	  soaked	  first	  in	  methanol	  in	  a	  shaker	  for	  1	  minute,	  then	  in	  water	  in	  a	  shaker	  for	  5	  minutes.	  PVDF	  membranes	  were	  then	  transferred	  into	  transfer	  buffer.	  The	  machine	  was	  set	  for	  transferring	  of	  protein	  bands	  from	  the	  Western	  Blotting	  gel	  onto	  the	  PVDF	  membrane.	  Sponges,	  gel,	  and	  PVDF	  membranes	  placed	  on	  top	  of	  each	  other	  according	  to	  the	  user	  guidelines	  and	  the	  machine	  was	  set	  to	  30V	  and	  run	  for	  1	  hour.	  In	  between	  the	  transferring,	  TBST	  buffer	  was	  prepared	  from	  1x	  TBS	  buffer	  with	  Tween	  20	  at	  0.05%	  final	  concentration.	  5%	  milk	  was	  then	  thawed	  in	  TBST	  on	  ice.	  After	  1	  hour	  of	  transferring,	  the	  membrane	  was	  incubated	  with	  5%	  milk	  for	  1	  hour	  at	  room	  temperature	  in	  a	  shaker.	  The	  membrane	  was	  then	  washed	  with	  TBST	  once.	  Anti-­‐Sirtuin-­‐1	  rabbit	  polyclonal	  antibody	  purchased	  from	  Merck	  Millipore	  was	  diluted	  1:500	  in	  10-­‐mL	  of	  TBST-­‐5%	  milk.	  The	  membrane	  was	  placed	  in	  middle	  size	  plastic	  box	  and	  the	  antibody	  solution	  was	  poured	  onto	  the	  membrane.	  The	  box	  was	  closed,	  wrapped	  with	  parafilm,	  and	  left	  on	  a	  shaker	  in	  cold	  room	  overnight.	  In	  the	  next	  day,	  the	  antibody	  solution	  on	  the	  membrane	  was	  pipetted	  out	  into	  a	  tube	  and	  placed	  in	  a	  freezer	  at	  -­‐20	  °C.	  The	  membrane	  was	  then	  washed	  three	  times	  with	  TBST	  with	  every	  washing	  lasting	  for	  10	  minutes.	  Before	  the	  last	  wash	  with	  TBST	  was	  completed,	  anti-­‐rabbit	  secondary	  antibody	  was	  diluted	  1:15000	  in	  10-­‐mL	  of	  TBST-­‐5%	  milk.	  The	  secondary	  antibody	  solution	  was	  added	  onto	  the	  membrane	  placed	  in	  a	  shaker	  box	  and	  kept	  for	  2	  hours	  on	  a	  shaker	  at	  room	  temperature.	  After	  the	  incubation	  with	  the	  secondary	  antibody	  solution,	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the	  membrane	  was	  washed	  again	  with	  TBST	  three	  times,	  each	  wash	  lasting	  for	  10	  minutes.	  The	  membrane	  was	  then	  placed	  on	  a	  transparent	  plastic	  layer	  and	  SuperSignal	  West	  Femto®	  chemiluminescent	  substrates	  purchased	  from	  Thermo	  Scientific	  were	  added	  onto	  the	  membrane	  and	  the	  membrane	  was	  immediately	  covered	  with	  aluminum	  foil	  since	  this	  step	  was	  light	  sensitive.	  The	  membrane	  was	  then	  imaged	  for	  Sirt1	  bands	  with	  Fuji	  Film	  Luminescent	  Image	  Analyzer	  LAS-­‐3000.	  After	  the	  imaging	  was	  complete,	  membrane	  was	  washed	  with	  TBST	  once	  and	  Anti-­‐β-­‐Actin	  antibody	  with	  1:5000	  dilution	  in	  10-­‐mL	  of	  TBST-­‐5%	  milk	  was	  added	  onto	  the	  membrane.	  The	  box	  where	  the	  membrane	  was	  placed	  was	  closed	  and	  wrapped	  with	  parafilm	  and	  left	  on	  the	  shaker	  in	  cold	  room	  overnight.	  In	  the	  following	  day,	  the	  actin	  antibody	  solution	  was	  pipetted	  out	  and	  the	  membrane	  was	  washed	  with	  TBST	  three	  times,	  each	  wash	  lasting	  for	  10	  minutes.	  The	  anti-­‐rabbit	  secondary	  antibody	  solution	  with	  1:15000	  dilution	  in	  10-­‐mL	  of	  TBST-­‐5%	  milk	  was	  added	  onto	  the	  membrane	  in	  a	  shaker	  box	  and	  left	  for	  2	  hours	  for	  shaking	  at	  room	  temperature.	  Membrane	  was	  then	  washed	  three	  times	  with	  TBST,	  each	  wash	  lasting	  for	  10	  minutes.	  SuperSignal	  West	  Femto®	  chemiluminescent	  substrates	  were	  added	  on	  the	  PVDF	  membrane	  and	  membrane	  was	  covered	  with	  aluminum	  foil	  since	  the	  substrates	  were	  light	  sensitive.	  The	  membrane	  was	  then	  used	  to	  take	  images	  of	  β-­‐Actin	  bands	  at	  different	  exposures	  with	  LAS-­‐3000.	  Band	  images	  at	  different	  exposures	  were	  then	  compared	  and	  the	  clearest	  ones	  were	  selected	  for	  protein	  quantification	  analysis	  with	  Image	  J.	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3.8.	  Isolation	  of	  Small	  Intestinal	  Crypts	  from	  Mice	  Donors	  	  Mice	  were	  first	  euthanized	  in	  C02	  chamber	  by	  constant	  flow	  of	  CO2	  into	  the	  chamber	  for	  5	  minutes.	  Mice	  were	  taken	  out	  of	  the	  chamber	  and	  cervical	  dislocation	  was	  done	  by	  applying	  pressure	  to	  the	  nape	  of	  the	  animal	  and	  pulling	  it	  from	  its	  tail	  in	  order	  to	  make	  sure	  that	  the	  animal	  was	  sacrificed	  properly.	  Small	  intestine	  was	  then	  removed	  together	  with	  stomach	  by	  making	  two	  cuts:	  one	  around	  stomach-­‐esophagus	  connection	  and	  one	  at	  small	  intestine-­‐cecum	  connection.	  Small	  intestine	  was	  then	  placed	  in	  a	  10-­‐cm	  dish	  filled	  with	  ice-­‐cold	  PBS.	  Feces	  inside	  the	  small	  intestine	  were	  removed	  by	  injecting	  PBS	  into	  the	  lumen.	  Fat	  and	  mesentery	  were	  also	  cleaned	  away	  by	  rubbing	  the	  intestine	  with	  fingers.	  Intestine	  was	  then	  opened	  longitudinally	  and	  gently	  rubbed	  between	  fingers	  in	  cold	  PBS	  to	  remove	  the	  mucus.	  Intestine	  was	  cleaned	  until	  it	  appeared	  pale	  pink	  color.	  Intestine	  was	  then	  cut	  into	  approximately	  3-­‐mm	  fragments	  and	  the	  fragments	  were	  placed	  into	  a	  50-­‐mL	  conical	  tube	  filled	  with	  30-­‐mL	  of	  ice	  cold	  PBS-­‐10-­‐mM	  EDTA.	  The	  tube	  was	  shaken	  intermittently	  on	  ice	  for	  45	  minutes	  discarding	  and	  replacing	  the	  supernatant	  once	  every	  15	  minutes.	  Fragments	  were	  then	  resuspended	  with	  ice	  cold	  30-­‐mL	  of	  PBS-­‐10mM	  EDTA.	  The	  tube	  was	  incubated	  on	  ice	  for	  60	  minutes	  and	  shaken	  gently	  every	  10	  minutes	  without	  changing	  the	  supernatant.	  Contents	  were	  then	  passed	  through	  a	  70-­‐μm	  filtering	  mesh	  in	  order	  to	  remove	  villous	  material	  and	  tissue	  fragments.	  The	  filtrate	  was	  centrifuged	  for	  6	  minutes	  at	  400g	  at	  room	  temperature.	  The	  supernatant	  was	  discarded	  and	  the	  pellet	  formed	  at	  the	  bottom	  of	  the	  tube	  was	  kept	  on	  ice.	  Pellet	  was	  then	  resuspended	  in	  1-­‐mL	  of	  fresh	  crypt	  culture	  media.	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3.9.	  Intestinal	  Crypt	  and	  Organoid	  Culturing	  
	  Crypts	  isolated	  from	  small	  intestine	  are	  resuspended	  in	  1-­‐mL	  of	  regular	  ENR	  media	  (see	  section	  3.11	  for	  media	  ingredients).	  Matrigel	  thawed	  on	  ice	  was	  used	  together	  with	  ENR	  media	  for	  crypt	  culturing.	  30-­‐μL	  drops	  containing	  60%	  Matrigel	  and	  40%	  crypts	  in	  ENR	  media	  were	  pipetted	  carefully	  to	  the	  center	  of	  wells	  of	  a	  48-­‐well	  plate	  while	  keeping	  the	  Matrigel	  and	  crypts	  resuspended	  in	  media	  on	  ice	  at	  all	  times.	  After	  the	  crypts	  were	  plated	  in	  Matrigel	  and	  media	  drops,	  the	  plate	  was	  kept	  in	  incubator	  for	  20	  minutes	  for	  the	  solidification	  of	  Matrigel.	  Later,	  plate	  was	  removed	  from	  the	  incubator	  and	  the	  drops	  were	  checked	  for	  proper	  solidification.	  If	  the	  drops	  were	  properly	  solidified,	  300-­‐μL	  of	  ENR	  media	  were	  added	  to	  the	  walls	  of	  each	  well.	  The	  surrounding	  wells	  received	  around	  100-­‐300-­‐μL	  of	  ddH20	  in	  order	  to	  prevent	  evaporation	  of	  the	  ENR	  media.	  	  The	  next	  day	  viable	  crypts	  form	  round	  organoids	  if	  cultured	  in	  ENR	  media	  with	  ingredients	  of	  proper	  amount.	  Organoids	  were	  passaged	  every	  2-­‐3	  days	  depending	  on	  their	  growth	  rate	  and	  viability.	  Surface	  of	  the	  wells	  were	  scratched	  with	  1-­‐mL	  sized	  pipette	  tip	  and	  the	  Matrigel	  was	  broken	  and	  mixed	  into	  the	  culture	  media.	  The	  media	  were	  then	  transferred	  into	  a	  15-­‐mL	  tube	  and	  the	  volume	  was	  increased	  to	  10-­‐mL	  by	  adding	  PBS.	  Organoids	  were	  then	  centrifuged	  for	  30	  sec	  at	  400g	  at	  room	  temperature.	  The	  supernatant	  was	  removed	  until	  1-­‐mL	  of	  it	  was	  left.	  Organoid	  pellet	  at	  the	  bottom	  of	  the	  tube	  was	  resuspended	  by	  pipetting	  up	  and	  down	  for	  10	  times.	  More	  PBS	  was	  added	  into	  the	  tube	  and	  the	  volume	  was	  increased	  up	  to	  10-­‐mL.	  The	  organoids	  were	  centrifuged	  again	  for	  another	  time	  at	  300g	  for	  1	  minute.	  The	  supernatant	  was	  pipetted	  out	  until	  200-­‐μL	  line.	  Organoid	  pellet	  was	  resuspended	  again	  in	  200-­‐μL	  volume	  with	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200-­‐μL	  pipette	  tip	  by	  pipetting	  up	  and	  down	  for	  20	  times.	  More	  PBS	  was	  added	  and	  organoids	  were	  centrifuged	  for	  a	  third	  and	  a	  last	  time	  for	  3	  minutes	  at	  300g	  at	  room	  temperature.	  The	  supernatant	  was	  then	  completely	  removed	  until	  only	  10-­‐20-­‐μL	  was	  left	  on	  the	  organoid	  pellet.	  Organoids	  were	  then	  resuspended	  in	  desired	  amount	  of	  ENR	  media	  and	  plated	  as	  stated	  above.	  The	  continuous	  centrifuging-­‐resuspending	  cycle	  was	  done	  in	  order	  to	  break	  the	  organoids	  into	  small	  crypts.	  When	  organoids	  are	  properly	  broken	  into	  crypts,	  each	  viable	  crypt	  forms	  a	  new	  organoid.	  Therefore,	  the	  whole	  purpose	  of	  passaging	  organoids	  is	  to	  break	  them	  into	  their	  smaller	  crypt	  units	  and	  restart	  the	  crypt	  to	  organoid	  growth	  process,	  obtaining	  more	  organoids.	  	  
3.10.	  Organoid	  Transduction	  with	  Lentivirus	  
	  Organoids	  were	  cultured	  for	  6	  days	  in	  regular	  ENR	  media	  containing	  1-­‐mM	  Valproic	  Acid	  and	  3-­‐μM	  CHIR	  compound.	  Organoids	  were	  passaged	  once	  in	  day	  -­‐2	  and	  media	  was	  changed	  once	  in	  every	  two	  days.	  In	  day	  0,	  lentiviral	  transduction	  of	  organoids	  with	  one	  non-­‐targeting	  virus	  and	  two	  Sirt-­‐1	  knockdown	  viruses	  was	  performed.	  Organoids	  were	  first	  mechanically	  detached	  from	  Matrigel	  by	  using	  a	  pipette	  tip	  and	  they	  were	  transferred	  into	  a	  15-­‐mL	  tube.	  Volume	  was	  increased	  up	  to	  10-­‐mL	  with	  PBS	  and	  the	  organoids	  were	  centrifuged	  for	  1	  minute	  at	  300g	  at	  room	  temperature.	  Supernatant	  was	  then	  removed	  until	  1-­‐mL	  of	  it	  was	  left.	  The	  organoid	  pellet	  was	  resuspended	  by	  pipetting	  up	  and	  down	  10	  times	  with	  a	  1000-­‐μL	  pipette	  tip.	  Second	  wash	  with	  PBS	  was	  done	  and	  organoids	  were	  centrifuged	  for	  2	  minutes	  at	  300g	  at	  room	  temperature.	  Supernatant	  was	  removed	  by	  suction	  until	  only	  200-­‐μL	  volume	  was	  left	  in	  the	  tube.	  Organoids	  were	  resuspended	  again	  by	  pipetting	  up	  and	  down	  20	  times	  with	  a	  200-­‐μL	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pipette	  tip.	  PBS	  was	  added	  into	  the	  tube	  to	  raise	  the	  volume	  to	  10-­‐mL.	  Organoids	  were	  centrifuged	  for	  the	  third	  and	  the	  last	  time	  for	  3	  minutes	  at	  300g	  at	  room	  temperature.	  Almost	  all	  of	  the	  supernatant	  was	  then	  removed	  by	  suction.	  120-­‐μL	  of	  DNAsI	  was	  added	  to	  500-­‐μL	  TrypLe	  and	  the	  mixture	  was	  then	  added	  on	  the	  organoid	  pellet.	  The	  organoids	  were	  pipetted	  up	  and	  down	  while	  keeping	  the	  tube	  on	  ice	  at	  all	  times.	  Organoids	  were	  then	  placed	  in	  water	  bath	  pre-­‐warmed	  to	  32	  °C	  and	  kept	  in	  for	  120	  seconds.	  Organoids	  were	  immediately	  placed	  back	  on	  ice	  and	  resuspended	  with	  12-­‐mL	  of	  cold	  SMEM	  with	  120-­‐μL	  DNAsI	  by	  pipetting	  up	  and	  down	  for	  3	  times.	  Resuspended	  organoids	  were	  then	  centrifuged	  for	  5	  minutes	  at	  400g.	  Supernatant	  was	  discarded	  and	  pellet	  was	  immediately	  placed	  back	  on	  ice.	  Organoid	  pellet	  was	  resuspended	  with	  total	  volume	  of	  125-­‐μL	  infection	  media	  (see	  Media	  section	  for	  all	  types	  of	  media	  ingredient	  details)	  and	  virus.	  Viruses	  were	  kept	  at	  -­‐80	  °C	  and	  thawed	  on	  ice	  few	  hours	  before	  infection.	  125-­‐μL	  of	  DMEM-­‐F12	  media	  was	  added	  to	  the	  resuspension	  and	  the	  volume	  was	  raised	  up	  to	  250-­‐μL.	  250-­‐μL	  of	  organoid	  and	  virus	  resuspension	  was	  then	  pipetted	  to	  a	  single	  well	  in	  a	  64-­‐well	  plate.	  Plate	  was	  spinned	  down	  for	  70	  minutes	  at	  600g	  at	  32	  °C.	  Plate	  was	  then	  incubated	  for	  1	  hour	  at	  37	  °C.	  Organoids	  in	  infection	  media	  were	  then	  transferred	  into	  eppendorf	  tubes	  and	  infection	  media	  was	  discarded	  after	  organoids	  were	  pelleted	  by	  centrifugation	  for	  5	  minutes	  at	  300g	  at	  room	  temperature.	  Organoids	  were	  then	  resuspended	  in	  48-­‐μL	  culture	  media	  and	  cultured	  as	  explained	  in	  the	  Intestinal	  Crypt	  and	  Organoid	  Culturing	  section	  of	  Materials	  and	  Methods.	  Culture	  media	  was	  changed	  every	  day.	  In	  day	  +2,	  48	  hours	  after	  lentiviral	  transduction	  of	  organoids,	  culture	  media	  was	  replaced	  with	  puromycin	  selection	  media.	  Organoid	  number	  was	  counted	  and	  images	  were	  taken	  at	  5X	  objective	  before	  changing	  the	  culture	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media	  to	  puromycin	  selection	  media.	  Puromycin	  selection	  media	  was	  kept	  on	  the	  infected	  organoids	  for	  2	  days	  and	  in	  day	  +4	  replaced	  with	  media	  for	  infected	  organoids.	  In	  day	  +5,	  media	  for	  infected	  organoids	  was	  replaced	  with	  regular	  ENR	  media.	  Media	  was	  changed	  every	  two	  days.	  In	  day	  +7,	  transduced	  organoids	  were	  counted	  and	  imaged.	  Organoids	  were	  kept	  growing	  in	  ENR	  media	  with	  media	  change	  in	  every	  2	  days	  until	  day	  +13.	  Organoids	  were	  checked	  everyday	  for	  organoid	  bubble	  structure	  formation,	  viability,	  and	  crypt	  budding.	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purposes.	  Organoids	  were	  divided	  into	  two	  main	  groups:	  control	  group	  receiving	  ENR	  media	  with	  different	  volumes	  of	  ethanol	  and	  experimental	  group	  receiving	  ENR	  media	  with	  different	  concentrations	  of	  resveratrol.	  	  It	  is	  important	  to	  underline	  that	  the	  control	  organoids	  were	  also	  divided	  into	  3	  groups,	  each	  group	  being	  the	  control	  of	  an	  experimental	  organoid	  group,	  which	  received	  ENR	  media	  of	  200-­‐μM,	  100-­‐μM,	  or	  50-­‐μM	  resveratrol.	  In	  day	  3,	  regular	  ENR	  media	  for	  six	  groups	  of	  organoids	  was	  replaced	  with	  ENR	  media	  with	  resveratrol	  dissolved	  in	  pure	  ethanol	  or	  ENR	  media	  only	  with	  pure	  ethanol.	  Organoids	  were	  grown	  in	  resveratrol	  for	  two	  days	  and	  in	  day	  5	  surviving	  organoids	  were	  counted	  and	  imaged	  at	  different	  objectives	  in	  wells	  that	  received	  either	  resveratrol	  or	  ethanol.	  In	  day	  5,	  media	  for	  organoids	  was	  replaced	  with	  fresh	  ENR	  media	  with	  or	  without	  resveratrol.	  In	  day	  6,	  more	  images	  were	  taken	  in	  order	  to	  count	  the	  average	  number	  of	  crypts	  per	  organoid.	  Images	  were	  also	  used	  and	  analyzed	  in	  Image	  J	  in	  order	  to	  measure	  crypt	  lengths	  and	  crypt	  widths.	  Paneth	  cells	  located	  at	  the	  crypt	  bottoms	  were	  counted	  under	  Light	  Microscope	  at	  40x	  objective	  and	  images	  were	  taken.	  Only	  the	  crypts	  that	  were	  growing	  perpendicular	  to	  z-­‐plane	  were	  included	  in	  Paneth	  cell	  counting	  analysis.	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4.	  Results	  
	  
4.1.	  Purification	  of	  Sirt-­‐1	  Plasmids	  of	  Interest	  	  	  Plasmids	  for	  targeting	  Sirt1	  gene	  in	  intestinal	  organoids	  were	  increased	  in	  copy	  number	  by	  bacterial	  culturing	  and	  isolated	  as	  stated	  in	  Materials	  and	  Methods	  section.	  Five	  plasmids	  with	  shRNA	  targeting	  sequences	  for	  Sirt1	  were	  constructed	  in	  pLKO.1	  backbone	  as	  shown	  in	  the	  table	  below.	  
Plasmid	  ID	   TRCN	  ID	   Target	  Sequence	  in	  Mouse	  Sirt1	   Vector	  	  
B01	   TRCN0000039296	   GAGGGTAATCAATACCTGTTT	   pLKO.1	  
B02	   TRCN0000039297	   CCTGAAAGAACTGTACCACAA	   pLKO.1	  
B03	   TRCN0000039298	   CGCGGATAGGTCCATATACTT	   pLKO.1	  
A11	   TRCN0000039294	   GCCATGTTTGATATTGAGTAT	   pLKO.1	  
A12	   TRCN0000039295	   GCCATGAAGTATGACAAAGAT	   pLKO.1	  	  
Plasmid	  ID	   Concentration	  (ng/uL)	   260/230	   260/280	  
B01	   147.5	   2.19	   1.95	  
B02	   302.3	   2.27	   1.84	  
B03	   212.8	   2.30	   1.92	  
A11	   106.5	   2.23	   1.98	  
A12	   266.3	   2.28	   1.80	  	  Purified	  plasmids	  were	  measured	  for	  their	  concentration,	  260/230,	  and	  260/280	  values	  with	  Nano	  Drop	  spectrophotometer.	  As	  shown	  in	  the	  table,	  purified	  plasmid	  DNA	  meet	  the	  purity	  criteria	  according	  to	  their	  absorbance	  values	  at	  different	  wavelengths.	  This	  indicates	  that	  the	  plasmids	  can	  be	  used	  for	  transfection	  and	  Sirt1	  targeting	  lentivirus	  production.	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4.2.	  Running	  Plasmid	  DNAs	  on	  Agarose	  Gel	  	  	  Plasmids	  that	  were	  shown	  to	  be	  pure	  from	  the	  absorbance	  values	  measured	  by	  a	  spectrophotometer,	  were	  also	  run	  on	  an	  agarose	  gel	  to	  see	  if	  there	  were	  any	  bacterial	  DNA	  contamination.	  This	  step	  was	  necessary	  to	  double	  prove	  the	  purity	  of	  the	  plasmids,	  which	  was	  important	  for	  successful	  transfection	  and	  virus	  production.	  Isolated	  plasmids	  demonstrated	  expected	  gel	  running	  patterns	  of	  closed	  circular	  and	  open	  circular	  forms,	  and	  were	  considered	  sufficient	  quality	  for	  lentivirus	  production	  
	  	  
4.3.	  Knocking	  Down	  Sirt-­‐1	  in	  NIH	  3T3	  Mouse	  Fibroblast	  Genome	  by	  Lentiviral	  
Transduction	  	  NIH	  3T3	  cells	  were	  infected	  with	  five	  different	  lentiviruses	  to	  identify	  the	  knockdown	  efficiency	  of	  each	  virus.	  An	  additional	  control	  lentivirus	  was	  also	  used	  to	  infect	  NIH	  3T3	  cells.	  This	  lentivirus	  was	  a	  non-­‐specific	  non-­‐targeting	  lentivirus,	  which	  integrated	  into	  a	  non-­‐coding	  region	  in	  cells	  genome.	  After	  different	  groups	  of	  NIH	  3T3	  cells	  were	  infected	  with	  either	  a	  control	  lentivirus	  or	  one	  of	  five	  lentiviruses	  with	  Sirt1	  knocking	  down	  potential,	  cells	  were	  grown	  for	  48	  hours	  in	  vitro.	  Selection	  marker	  puromycin	  was	  added	  in	  media	  after	  48	  hours	  of	  growth	  and	  was	  kept	  on	  the	  cells	  for	  another	  48	  hours.	  Cells,	  which	  were	  not	  infected	  by	  a	  lentivirus,	  were	  not	  able	  to	  survive	  in	  the	  media	  
Fig	  1.	  Gel	  electrophoresis	  image	  of	  plasmid	  
DNAs.	  From	  left	  to	  right:	  1.5Kb	  DNA	  ladder,	  B1,	  B2,	  B3,	  loading	  error,	  A11,	  and	  A12	  plasmids.	  As	  seen	  in	  the	  figure	  provided,	  all	  plasmids	  existed	  in	  two	  different	  confirmations	  with	  no	  sign	  of	  bacterial	  DNA	  contamination	  or	  plasmid	  DNA	  digestion.	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containing	  1.5-­‐μg/mL	  puromycin.	  However,	  cells	  which	  had	  a	  lentivirus	  integrated	  in	  their	  genome	  were	  resistant	  to	  the	  killing	  effect	  of	  puromycin	  since	  the	  pLKO.1	  backbone	  in	  the	  virus	  genome	  had	  the	  gene	  for	  puromycin	  resistance.	  After	  the	  puromycin	  media	  was	  taken	  out,	  cells	  were	  observed	  to	  determine	  percent	  cell	  viability.	  Viability	  of	  80-­‐90%	  would	  indicate	  that	  the	  lentivirus	  had	  high	  viral	  infecting	  efficiency	  and	  could	  potentially	  be	  used	  for	  transducing	  more	  difficult	  targets,	  such	  as	  intestinal	  organoids.	  Exposure	  to	  puromycin	  for	  48	  hours	  almost	  killed	  all	  of	  the	  NIH	  3T3	  cells	  that	  were	  transduced	  by	  either	  B01	  or	  A12	  virus.	  Cells	  infected	  with	  non-­‐targeting,	  B02,	  B03,	  and	  A11-­‐lentivirus	  had	  a	  surviving	  rate	  of	  approximately	  80%,	  which	  was	  determined	  with	  an	  experienced	  eye.	  For	  the	  western	  blotting	  experiment	  needed	  for	  determining	  the	  knockdown	  efficiency	  of	  each	  lentivirus,	  NIH	  3T3	  cells	  transduced	  with	  one	  of	  the	  four	  lentiviruses	  were	  used:	  Non-­‐targeting,	  B02,	  B03,	  and	  A11.	  Lentiviruses	  B01	  and	  A12	  were	  omitted	  from	  further	  experiments	  since	  they	  were	  not	  successfully	  able	  to	  infect	  their	  target	  cells.	  
4.4.	  Western	  Blotting	  of	  NIH	  3T3	  Cells	  Transduced	  by	  a	  Sirt-­‐1	  Targeting	  Lentivirus	  	  Protein	  concentrations	  of	  lysates	  of	  NIH	  3T3-­‐shRNA-­‐Non-­‐targeting	  and	  NIH	  3T3-­‐shRNA-­‐SIRT1-­‐KD	  cells	  were	  calculated	  according	  to	  the	  protocol	  provided	  in	  Materials	  and	  Methods	  section.	  Absorbance	  level	  of	  each	  lysate	  was	  measured	  by	  a	  spectrophotometer	  and	  the	  protein	  concentrations	  of	  cell	  lysates	  were	  determined	  by	  using	  BSA	  protein	  linear-­‐fit	  standard	  curve	  as	  shown	  in	  the	  table	  below.	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  Logic	  behind	  using	  BSA	  standard	  curve	  is	  as	  follows:	  BSA	  samples	  with	  pre-­‐known	  range	  of	  concentrations	  were	  used	  to	  measure	  their	  absorbance.	  The	  obtained	  data	  was	  then	  used	  to	  construct	  a	  linear	  fit,	  which	  shows	  a	  positive	  linear	  correlation	  between	  protein	  concentration	  and	  absorbance.	  	  Below	  are	  the	  protein	  concentrations	  of	  lysates	  of	  transduced	  cells	  that	  were	  calculated	  by	  using	  the	  BSA	  standard	  linear	  fit	  equation.	  	  	  	  	  	  11.5	  μg	  of	  protein	  from	  the	  lysates	  of	  transduced	  NIH	  3T3	  cells	  were	  loaded	  into	  the	  Western	  Blotting	  lanes	  and	  the	  volume	  to	  be	  loaded	  was	  calculated	  from	  the	  protein	  concentrations.	  	  	  












Protein	  Concentration	  (ug/uL)	  
BSA	  Standard	  Curve	  
BSA	  Linear	  (BSA)	  
Cell	  Lysate	   Absorbance	   Protein	  Concentration	  (μg/μL)	  
sh	  Non-­‐Targeting	   0.702	   0.546	  
sh	  SIRT1-­‐KD	  B2	   0.57	   0.439	  
sh	  SIRT1-­‐KD	  B3	   0.558	   0.4295	  
sh	  SIRT1-­‐KD	  A11	   0.6	   0.4635	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4.5.	  Western	  Blot	  Image	  and	  Analysis	  of	  Percent	  Knock	  Down	  of	  Sirt-­‐1	  	  	  NIH	  3T3	  cells	  transduced	  with	  lentiviruses	  knocking	  down	  the	  expression	  of	  Sirt-­‐1	  gene	  at	  mRNA	  level	  via	  shRNA	  method	  were	  analyzed	  to	  determine	  the	  knock	  down	  efficiency	  of	  each	  lentivirus.	  Purpose	  of	  conducting	  this	  experiment	  was	  to	  identify	  the	  two	  most	  suitable	  lentiviruses	  for	  mouse	  intestinal	  organoid	  transduction,	  which	  perform	  the	  highest	  Sirt-­‐1	  knockdown	  levels.	  	  Figure	  2	  below	  shows	  the	  image	  of	  SIRT-­‐1	  and	  β-­‐Actin	  bands	  on	  PVDF	  membrane	  captured	  at	  the	  optimal	  exposure	  time	  of	  20	  seconds.	  	  
	  
	  	  In	  each	  knock	  down	  cell	  line,	  it	  is	  clear	  that	  Sirt-­‐1	  gene	  was	  knocked	  down	  successfully	  since	  the	  ratio	  of	  β-­‐	  Actin/Sirt1	  in	  all	  Sirt1-­‐targeted	  cell	  lines	  was	  dramatically	  lower	  in	  cells	  transduced	  with	  the	  control	  virus.	  To	  quantify	  the	  results,	  Image	  J	  program	  was	  used:	  β-­‐	  Actin	  levels	  were	  normalized	  and	  area-­‐under-­‐curve	  (AUC)	  of	  each	  Sirt-­‐1	  band	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Fig	  2.	  Western	  Blotting	  Image	  of	  NIH	  3T3	  Whole	  Cell	  Lysates.	  	  Sirt1	  gene	  was	  knocked	  down	  in	  all	  models.	  Lane	  1	  contains	  proteins	  from	  cells	  transduced	  with	  Non-­‐specific	  Non-­‐Sirt-­‐1	  targeting	  lentivirus.	  Lane	  2	  has	  cellular	  proteins	  of	  Sirt-­‐1	  Knocking	  Down	  B2-­‐lentivirus.	  Lane	  3	  has	  proteins	  of	  cells	  transduced	  with	  Sirt-­‐1	  Knocking	  Down	  B3-­‐lentivirus.	  Lane	  4	  has	  proteins	  of	  cells	  transduced	  with	  Sirt-­‐1	  Knocking	  Down	  A11-­‐lentivirus.	  Lanes	  were	  analyzed	  in	  Image	  J	  to	  determine	  the	  two	  best	  Sirt-­‐1	  knock	  down	  models.	  Western	  blotting	  was	  conducted	  and	  images	  were	  captured	  as	  described	  in	  Section	  2.7	  of	  Materials	  and	  Methods.	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were	  multiplied	  with	  the	  normalization	  factor	  obtained	  from	  the	  analysis	  of	  β-­‐	  Actin	  bands.	  Results	  from	  AUC	  multiplied	  with	  normalization	  factor	  were	  then	  compared	  to	  each	  other.	  AUC	  x	  Normalization	  factor	  of	  control	  cells	  were	  accepted	  as	  100%	  Sirt-­‐1	  expressed	  (0%	  knockdown).	  AUC	  x	  Normalization	  factor	  of	  other	  models	  were	  then	  compared	  to	  the	  value	  of	  control	  cells	  and	  percent	  expression	  of	  Sirt-­‐1	  gene	  in	  NIH	  3T3	  cells	  transduced	  with	  Sirt-­‐1	  knocking	  down	  lentivirus	  was	  calculated	  as	  shown	  in	  table	  below.	  sh-­‐SIRT-­‐1	  B2	  and	  sh-­‐SIRT-­‐1	  A11	  were	  chosen	  for	  mouse	  intestinal	  organoid	  transduction	  experiment	  as	  these	  lentiviruses	  exhibited	  the	  two	  highest	  Sirt-­‐1	  knockdown	  levels	  as	  seen	  in	  Figure	  3.	  	  


















Fig	  3.	  Percent	  expression	  of	  SIRT-­‐1	  gene	  in	  NIH	  3T3	  cells	  after	  the	  
transduction	  with	  SIRT-­‐1	  targeting	  lentivirus.	  Lane	  images	  were	  analyzed	  on	  Image	  J	  and	  β-­‐	  Actin	  bands	  were	  utilized	  for	  normalization	  purposes.	  According	  to	  the	  results,	  shSIRT1	  B2	  and	  shSIRT1	  A11	  lentiviruses	  exhibited	  the	  highest	  knockdown	  of	  the	  target	  gene	  in	  NIH	  3T3	  cells.	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4.6.	  Knock	  Down	  of	  Sirt-­‐1	  Gene	  in	  Mouse	  Intestinal	  Organoids	  by	  Lentiviral	  
Transduction	  	  Mouse	  intestinal	  organoids	  cultured	  in	  CV	  media	  for	  6	  days	  were	  transduced	  with	  non-­‐targeting,	  Sirt-­‐1	  targeting	  sh-­‐B2,	  and	  Sirt-­‐1	  targeting	  sh-­‐A11	  lentiviruses	  as	  described	  in	  part	  3.10	  of	  Materials	  and	  Methods	  section.	  Intestinal	  organoids	  were	  grown	  in	  culture	  media	  for	  infected	  organoids	  for	  2-­‐days	  followed	  by	  changing	  the	  media	  to	  puromycin	  selection	  media.	  During	  the	  selection,	  organoids	  that	  were	  disintegrated	  into	  single	  cells	  or	  clusters	  of	  cells	  during	  the	  infection	  process	  started	  to	  re-­‐grow	  into	  new	  organoids.	  Images	  of	  re-­‐growing	  organoids	  were	  captured	  and	  organoids	  were	  counted	  under	  the	  microscope	  before	  culture	  media	  for	  infected	  organoids	  was	  changed	  to	  puromycin	  selection	  media.	  Fig	  4.	  shows	  the	  captured	  images	  of	  organoids	  with	  5x	  objective	  just	  before	  the	  addition	  of	  puromycin	  selection	  media.	  Two	  days	  after	  the	  transduction,	  intestinal	  organoids	  that	  were	  transduced	  with	  different	  lentiviruses	  were	  grown	  to	  different	  sizes.	  As	  seen	  in	  Fig	  4.	  Intestinal	  organoids	  that	  were	  infected	  with	  a	  Sirt-­‐1	  knockdown	  lentivirus	  were	  much	  bigger	  in	  size	  compared	  to	  the	  organoids	  that	  were	  either	  infected	  with	  a	  non-­‐targeting	  lentivirus	  or	  no	  virus	  at	  all.	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  Two	  days	  after	  puromycin	  selection	  media	  was	  added,	  media	  was	  changed	  to	  regular	  ENR	  media	  and	  the	  surviving	  organoids	  were	  grown	  for	  three	  days	  before	  counting.	  Fig	  5.	  shows	  the	  percent	  of	  organoids	  surviving	  3	  days	  after	  puromycin	  selection	  was	  complete.	  	  
Fig	  4.	  Mouse	  Intestinal	  Organoids	  Two	  Days	  Post-­‐Transduction.	  All	  images	  were	  captured	  at	  5x	  objective.	  Organoids,	  which	  were	  exposed	  to	  infection	  process	  with	  one	  of	  SIRT-­‐1	  knocking	  down	  lentivirus	  were	  bigger	  in	  size	  compared	  to	  organoids	  which	  were	  infected	  with	  control	  virus	  or	  non-­‐infected	  organoids.	  Note	  that	  at	  this	  stage	  it	  was	  not	  yet	  proven	  if	  all	  
these	  organoids	  were	  successfully	  transduced.	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Fig	  5.	  	  Percent	  of	  Mouse	  Intestinal	  Organoids	  Surviving	  after	  Puromycin.	  Organoids	  were	  counted	  just	  before	  puromycin	  selection	  and	  3	  days	  after	  puromycin	  selection.	  No	  organoids	  were	  surviving	  in	  non-­‐infected	  and	  control	  virus	  transduced	  groups.	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  Intestinal	  organoids	  shown	  in	  Fig	  6-­‐A.	  were	  identified	  as	  living	  organoids	  since	  they	  were	  all	  rounded	  up	  and	  in	  bubble-­‐form.	  In	  Fig	  6-­‐B-­‐C-­‐D,	  organoids	  were	  surrounded	  with	  dead	  cells.	  These	  cells	  are	  likely	  to	  present	  uninfected	  cells	  of	  the	  original	  cell	  cluster	  that	  have	  died	  during	  the	  selection	  process.	  Normally,	  the	  differentiated	  dead	  cells	  that	  have	  completed	  their	  task	  and	  die	  via	  apoptosis	  are	  dumped	  into	  the	  lumen	  of	  the	  organoids.	  In	  Fig	  6-­‐A,	  organoid	  already	  demonstrates	  the	  formation	  of	  a	  crypt	  bud	  located	  at	  the	  top	  side	  of	  its	  lumen	  only	  3	  days	  after	  selection	  antibiotic	  puromycin	  was	  removed	  from	  the	  media.	  	  Infected	  mouse	  intestinal	  organoids	  that	  were	  able	  to	  survive	  the	  puromycin	  selection	  were	  grown	  for	  another	  6	  days	  in	  regular	  ENR	  media	  with	  change	  of	  media	  in	  every	  2	  
Fig	  6.	  Mouse	  intestinal	  organoids	  transduced	  with	  SIRT-­‐1	  targeting	  
lentivirus.	  Organoids	  were	  successfully	  transduced	  since	  they	  were	  able	  to	  survive	  in	  media	  containing	  puromycin.	  A-­‐B.	  Surviving	  organoids	  transduced	  with	  SIRT-­‐1	  targeting	  lentivirus	  B2.	  C-­‐D.	  Surviving	  organoids	  transduced	  with	  SIRT-­‐1	  targeting	  lentivirus	  A11.	  Images	  were	  taken	  at	  10x	  objective.	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days.	  During	  these	  6	  days,	  most	  of	  the	  intestinal	  organoids	  that	  were	  infected	  with	  a	  SIRT-­‐1	  targeting	  lentivirus	  were	  not	  able	  to	  regenerate	  new	  crypts	  and	  died.	  Only	  2	  out	  of	  76	  organoids	  transduced	  with	  B2	  lentivirus	  were	  able	  to	  survive	  (counted	  on	  9	  days	  post	  puromycin	  selection).	  All	  other	  organoids	  remained	  in	  a	  shape	  of	  a	  single	  spheroid,	  indicating	  that	  they	  could	  not	  produce	  new	  crypts,	  and	  died.	  In	  contrast,	  the	  2	  surviving	  organoids,	  which	  were	  both	  infected	  with	  Sirt-­‐1	  targeting	  B2	  lentivirus,	  were	  growing	  and	  regenerating	  new	  crypt	  buds	  as	  seen	  in	  Fig	  7.	  	  
	  	  	  	  	   	  	   	  	  	  	  
	   	  	  	  	  
	  	  
	  	  
Fig	  7.	  A-­‐B.	  Only	  two	  mouse	  intestinal	  organoids	  transduced	  with	  SIRT-­‐1	  
knocking	  down	  B2	  lentivirus	  regenerated	  multiple	  crypt	  domains.	  All	  other	  transduced	  organoids	  (both	  B2	  and	  A11	  transduced)	  were	  either	  dead	  or	  couldn’t	  regenerate	  by	  the	  time	  these	  two	  organoids	  were	  able	  to	  regenerate	  new	  crypt	  domains.	  C-­‐D.	  Clearly	  showing	  two	  organoids,	  transduced	  with	  A11	  lentivirus,	  which	  were	  still	  alive	  but	  could	  not	  regenerate.	  All	  four	  images	  were	  taken	  at	  the	  same	  day	  (day	  9	  post	  puromycin	  selection)	  with	  10x	  objective.	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4.7.	  Activation	  of	  Sirt-­‐1	  Gene	  in	  Mouse	  Intestinal	  Organoids	  
	  Resveratrol	  prepared	  at	  different	  concentrations	  in	  Regular	  ENR	  Media	  was	  applied	  on	  mouse	  intestinal	  organoids	  grown	  in	  vitro	  embedded	  in	  Matrigel	  for	  3	  days.	  Control	  organoids	  received	  regular	  ENR	  Media	  with	  equal	  amount	  of	  pure	  ethanol	  that	  the	  resveratrol	  group	  received.	  Fig	  8.	  shows	  the	  images	  of	  groups	  of	  organoids	  before	  the	  addition	  of	  ENR	  media	  containing	  resveratrol.	  Images	  are	  all	  taken	  from	  the	  center	  of	  the	  wells	  on	  day	  3	  of	  the	  experiment	  with	  5x	  objective.	  Organoids	  in	  each	  well	  were	  also	  counted	  in	  order	  to	  make	  sure	  that	  all	  experimental	  groups	  were	  formed	  by	  approximately	  equal	  number	  of	  organoids.	  Images	  taken	  at	  5x	  objective	  show	  that	  crypts	  had	  rounded	  up	  and	  formed	  organoids,	  and	  were	  therefore	  at	  a	  morphologically	  preferred	  phase	  to	  initiate	  the	  experiment.	  Most	  of	  the	  organoids	  were	  just	  starting	  to	  have	  new	  crypt	  buds.	  In	  general,	  organoids	  were	  equally	  viable	  and	  at	  the	  very	  early	  stages	  of	  their	  growth.	  This	  was	  the	  perfect	  point	  to	  add	  a	  new	  chemical	  like	  resveratrol	  into	  the	  organoid	  media	  to	  see	  how	  the	  chemical	  could	  affect	  certain	  biological	  characteristics	  of	  the	  organoids	  such	  as	  the	  number	  of	  crypts	  budding	  from	  an	  organoid,	  crypt	  length,	  crypt	  width,	  and	  Paneth	  cell	  count	  at	  crypt	  bottom/tip.	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Fig	  8.	  Mouse	  intestinal	  organoids	  before	  the	  addition	  of	  ENR	  media	  with	  
resveratrol.	  All	  organoids	  were	  equally	  viable	  and	  at	  the	  similar	  stages	  of	  their	  growth	  phase	  possessing	  visibly	  formed	  round	  lumen	  and	  few	  newly	  budding	  crypts.	  Images	  were	  captured	  at	  5x	  objective.	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Fig	  9.	  Percent	  of	  organoids	  surviving	  after	  two	  days	  exposure	  to	  resveratrol	  in	  
ENR	  media.	  Organoids,	  which	  were	  grown	  in	  ENR	  media	  containing	  200-­‐μM	  resveratrol,	  had	  the	  lowest	  survival	  rate	  when	  compared	  to	  its	  control	  group	  receiving	  equal	  amount	  of	  pure	  ethanol	  but	  no	  resveratrol.	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When	  the	  percentage	  of	  organoids	  surviving	  in	  each	  resveratrol	  receiving	  group	  was	  compared	  to	  its	  corresponding	  control	  group,	  the	  biggest	  difference	  was	  seen	  among	  organoids,	  which	  were	  grown	  in	  ENR	  media	  containing	  200-­‐μM	  resveratrol	  and	  its	  control	  group.	  Even	  though	  the	  experimental	  groups,	  which	  received	  either	  50-­‐μM	  or	  100-­‐μM	  Resveratrol,	  had	  few	  more	  organoids	  dying	  compared	  to	  their	  control	  groups,	  the	  difference	  was	  as	  low	  as	  7-­‐8%.	  Organoids,	  which	  received	  equal	  amount	  of	  pure	  ethanol	  that	  the	  resveratrol	  200-­‐μM	  group	  received,	  had	  survivability	  rate	  of	  88%	  whereas	  the	  experimental	  group	  that	  received	  ENR	  media	  with	  200-­‐μM	  had	  only	  7.4%	  of	  its	  organoids	  surviving.	  In	  resveratrol	  200-­‐μM	  group,	  only	  2	  out	  of	  27	  organoids	  were	  surviving	  after	  they	  were	  grown	  in	  ENR	  media	  with	  200-­‐μM	  resveratrol	  for	  2	  days.	  Two	  surviving	  organoids	  were	  also	  different	  in	  morphology	  compared	  to	  organoids	  of	  the	  control	  group;	  both	  organoids	  had	  only	  their	  lumens	  formed	  with	  no	  crypt	  budding.	  On	  the	  contrary,	  control	  organoids	  had	  multiple	  crypts	  regenerating	  from	  the	  lumen	  as	  seen	  in	  Fig	  10.	  	  
	  	  	  
Fig	  10.	  Organoids	  after	  2	  days	  growth	  in	  ENR	  media	  containing	  different	  
concentrations	  of	  resveratrol.	  In	  all	  groups	  of	  organoids	  except	  the	  group,	  which	  received	  ENR	  media	  with	  200-­‐μM	  resveratrol,	  surviving	  and	  budding	  organoids	  can	  be	  observed.	  It	  is	  important	  to	  note	  that	  the	  images	  can	  be	  misleading	  at	  the	  first	  glance	  because	  organoids	  are	  embedded	  in	  a	  three	  dimensional	  matrix	  and	  it	  is	  not	  possible	  to	  image	  them	  all	  with	  high	  definition	  since	  they	  are	  located	  at	  different	  layers	  along	  the	  z-­‐axis.	  Dead	  organoids	  can	  be	  differentiated	  from	  living	  ones	  by	  observing	  the	  randomly	  dispersed	  cells	  located	  close	  to	  each	  other,	  which	  used	  to	  make	  up	  a	  living	  organoid.	  (Images	  are	  provided	  in	  the	  next	  page).	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4.8.	  Effects	  of	  Resveratrol	  on	  the	  Regeneration	  of	  Intestinal	  Crypts	  	  In	  day	  6,	  images	  of	  organoids	  were	  taken	  in	  order	  to	  analyze	  the	  morphological	  characteristics	  of	  organoids	  exposed	  to	  different	  concentrations	  of	  resveratrol.	  First,	  crypts	  of	  13-­‐17	  organoids	  from	  each	  experimental	  and	  control	  group	  were	  counted	  and	  the	  average	  crypt	  number	  per	  organoid	  was	  calculated.	  Organoids,	  which	  received	  200-­‐μM	  resveratrol,	  were	  not	  included	  in	  any	  of	  the	  following	  analysis	  since	  all	  organoids	  were	  dead	  by	  day	  6.	  Control	  organoids	  that	  received	  200μM	  of	  pure	  ethanol	  were	  also	  omitted	  from	  any	  further	  analysis.	  In	  addition,	  not	  all	  organoids	  were	  used	  in	  the	  analysis	  because	  some	  organoids	  had	  too	  many	  crypts	  budding	  from	  the	  organoid	  lumen	  in	  all	  directions	  in	  all	  three	  planes.	  So,	  it	  was	  not	  possible	  to	  accurately	  count	  these	  organoids	  and	  the	  decision	  was	  to	  leave	  them	  out	  of	  the	  analysis.	  However,	  there	  was	  almost	  equal	  number	  of	  organoids	  that	  had	  uncountable	  number	  of	  crypts	  in	  each	  group	  including	  the	  control	  groups	  that	  received	  no	  resveratrol,	  which	  was	  an	  indication	  that	  leaving	  these	  organoids	  out	  of	  the	  analysis	  wouldn’t	  affect	  the	  final	  result.	  According	  to	  the	  analysis,	  organoids	  that	  received	  ENR	  media	  with	  resveratrol	  showed	  a	  trend	  for	  having	  fewer	  crypts	  per	  organoid	  in	  average	  compared	  to	  the	  control	  organoids,	  which	  received	  only	  ENR	  media	  with	  pure	  ethanol.	  Two-­‐tailed	  T-­‐test	  analysis	  was	  then	  performed	  in	  order	  to	  determine	  if	  the	  difference	  in	  the	  average	  number	  of	  crypts	  per	  organoid	  in	  different	  experimental	  groups	  was	  statistically	  significant.	  According	  to	  the	  P-­‐values	  shown	  in	  Fig	  11	  difference	  in	  the	  average	  number	  of	  crypts	  per	  organoid	  among	  different	  organoid	  groups	  was	  not	  statistically	  significant.	  So,	  it	  is	  possible	  to	  conclude	  that	  in	  this	  one	  experiment	  resveratrol	  had	  no	  significant	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effect	  on	  the	  average	  number	  of	  crypts	  per	  organoid	  at	  50-­‐μM	  and	  100-­‐μM	  concentrations.	  However,	  repeat	  experiments	  that	  would	  allow	  statistical	  comparison	  of	  average	  crypt	  numbers,	  not	  distribution	  of	  crypts	  numbers	  in	  a	  single	  experiment	  would	  be	  necessary	  to	  conclude	  whether	  resveratrol	  has	  effects	  on	  the	  crypt	  number.	  Since	  all	  of	  the	  organoids	  that	  were	  treated	  with	  200-­‐μM	  resveratrol	  in	  ENR	  media	  were	  dead,	  we	  assume	  that	  resveratrol	  in	  high	  concentrations	  can	  be	  lethal	  for	  intestinal	  organoids	  and	  inhibit	  the	  crypt	  budding	  completely.	  However,	  in	  lower	  concentrations,	  resveratrol	  had	  no	  measured	  or	  observed	  effect	  on	  the	  average	  number	  of	  crypts	  budding	  from	  an	  intestinal	  organoid.	  	  
	   	  	  	  	  	  	  
	  	  













Average	  Number	  of	  Crypts	  
per	  Organoid	   Ethanol	  50	  Resveratrol	  50uM	  Ethanol	  100	  Resveratrol	  100uM	  
Fig	  11.	  Average	  number	  of	  crypts	  of	  organoids	  exposed	  to	  resveratrol	  
for	  2	  days.	  Crypt	  buds	  of	  intestinal	  organoids	  treated	  with	  a	  range	  of	  resveratrol	  concentration	  were	  counted	  and	  the	  average	  number	  of	  crypts	  for	  each	  experimental	  and	  control	  groups	  were	  calculated.	  Two-­‐tailed	  T-­‐test	  was	  performed	  and	  the	  calculated	  difference	  in	  the	  average	  number	  of	  crypts	  per	  organoid	  was	  found	  to	  be	  statistically	  insignificant	  as	  shown	  above.	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4.9.	  Effect	  of	  Resveratrol	  on	  Crypt	  Morphology	  
	  
4.9.1.	  Crypt	  Length	  	  	  Other	  morphological	  characteristics	  that	  were	  at	  the	  center	  of	  interest	  were	  average	  crypt	  length	  and	  average	  crypt	  width.	  Image	  J	  was	  used	  in	  order	  to	  measure	  the	  crypt	  length	  and	  width	  and	  determine	  if	  resveratrol	  had	  any	  effect	  on	  the	  size	  and	  the	  length	  of	  the	  regenerating	  crypts.	  Crypt	  lengths	  were	  measured	  from	  the	  side	  of	  the	  lumen	  until	  the	  tip	  of	  the	  crypt	  bud.	  Crypt	  widths	  were	  measured	  only	  at	  the	  tip	  of	  the	  crypts,	  where	  the	  crypts	  were	  visibly	  narrowed.	  	  According	  to	  the	  results	  and	  statistical	  analysis,	  it	  is	  possible	  to	  state	  that	  the	  organoids	  treated	  with	  50-­‐μM	  resveratrol	  in	  ENR	  media	  had	  shorter	  crypts	  compared	  to	  the	  control	  organoids	  which	  received	  only	  the	  same	  amount	  of	  pure	  ethanol	  in	  ENR	  media.	  However,	  difference	  in	  average	  crypt	  length	  was	  not	  statistically	  significant	  in	  between	  the	  organoid	  group	  treated	  with	  100-­‐μM	  resveratrol	  and	  its	  corresponding	  control	  group.	  The	  statistical	  insignificance	  in	  the	  result	  might	  be	  caused	  by	  the	  effect	  of	  higher	  volume	  of	  ethanol	  in	  ENR	  media	  on	  average	  crypt	  length.	  Analysis	  of	  the	  results	  on	  average	  crypt	  lengths	  of	  organoids	  treated	  with	  different	  concentrations	  of	  resveratrol	  shows	  that	  resveratrol	  in	  low	  concentrations	  (50-­‐μM)	  have	  an	  inhibiting	  effect	  on	  the	  average	  length	  of	  the	  crypts	  whereas	  it	  has	  no	  further	  effect	  on	  average	  crypt	  length	  if	  the	  resveratrol	  concentration	  was	  doubled	  (100-­‐μM).	  However,	  also	  the	  organoids	  treated	  with	  100μM	  resveratrol	  trend	  towards	  having	  shorter	  crypts	  than	  their	  control	  counterparts.	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4.9.2.	  Crypt	  Width	  	  Width	  of	  regenerating	  intestinal	  crypt	  buddings	  were	  measured	  and	  analyzed	  to	  determine	  if	  resveratrol	  in	  ENR	  media	  had	  an	  effect	  on	  the	  size	  of	  the	  crypt	  buddings.	  Only	  crypts	  that	  were	  growing	  perpendicular	  to	  the	  z-­‐axis	  were	  included	  in	  the	  analysis	  in	  order	  to	  accurately	  measure	  the	  crypt	  widths.	  Around	  11-­‐13	  crypts	  from	  each	  group	  meeting	  the	  criteria	  for	  inclusion	  in	  analysis	  were	  measured	  and	  the	  average	  size	  of	  crypt	  widths	  were	  calculated.	  Two-­‐tailed	  T-­‐test	  was	  used	  to	  see	  if	  the	  differences	  in	  average	  measurements	  were	  statistically	  significant.	  Organoids	  grown	  in	  ENR	  media	  containing	  50-­‐μM	  resveratrol	  had	  in	  average	  crypt	  widths	  in	  the	  size	  of	  36.8-­‐μm	  
127.2	  












Average	  Crypt	  Length	  	  
Ethanol	  50	  Resveratrol	  50uM	  Ethanol	  100	  Resveratrol	  100uM	  
Fig	  12.	  Average	  crypt	  length	  of	  organoids	  treated	  with	  resveratrol	  for	  2	  days.	  Crypt	  lengths	  of	  intestinal	  organoids	  treated	  with	  different	  concentrations	  of	  resveratrol	  were	  measured	  by	  using	  Image	  J	  and	  the	  average	  length	  for	  experimental	  and	  control	  groups	  were	  calculated.	  Two-­‐tailed	  T-­‐testing	  was	  done	  to	  show	  the	  significance	  level	  of	  the	  differences	  in	  average	  crypt	  lengths	  of	  organoids	  between	  experimental	  and	  control	  groups.	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Width	  (um)	  	  
Experiment	  Groups	  
Average	  Crypt	  Width	  
Ethanol	  50	  Resveratrol	  50uM	  Ethanol	  100	  Resveratrol	  100uM	  
Fig	  13.	  Average	  crypt	  width	  of	  organoids	  grown	  in	  resveratrol	  containing	  
media	  for	  2	  days.	  Crypt	  width	  of	  organoids	  treated	  with	  different	  concentrations	  of	  resveratrol	  in	  ENR	  media	  were	  measured	  in	  Image	  J	  and	  the	  average	  values	  shown	  above	  were	  calculated.	  Two-­‐tailed	  T-­‐test	  was	  used	  to	  determine	  the	  p	  values	  and	  the	  statistical	  significance	  of	  the	  results.	  Analysis	  shows	  that	  application	  of	  resveratrol	  on	  organoids	  reduced	  the	  regenerating	  crypt	  bottom	  widths	  at	  a	  statistically	  significant	  level.	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4.10.	  Effect	  of	  Resveratrol	  on	  Paneth	  Cell	  Count	  in	  the	  Crypt	  Bottoms	  of	  Intestinal	  
Organoids	  	  	  Paneth	  cells	  residing	  at	  the	  bottom	  of	  the	  crypts	  in	  intestinal	  organoids	  were	  imaged	  and	  counted	  under	  microscope	  according	  to	  their	  granularity	  and	  shape	  (See	  Figure	  15).	  Fig	  14.	  shows	  the	  average	  number	  of	  Paneth	  cells	  counted	  under	  the	  light	  microscope	  at	  40x.	  10	  crypts	  from	  each	  organoid	  group	  meeting	  the	  similar	  inclusion	  criteria	  that	  was	  set	  for	  crypt	  length	  and	  width	  measurements	  were	  imaged	  for	  their	  Paneth	  cells	  and	  the	  visible	  Paneth	  cells	  were	  also	  counted.	  In	  average,	  Paneth	  cell	  number	  per	  crypt	  bud	  was	  measured	  to	  be	  much	  higher	  in	  the	  control	  groups	  than	  the	  resveratrol	  receiving	  groups.	  In	  the	  organoid	  group	  grown	  in	  50-­‐μM	  resveratrol,	  average	  Paneth	  cell	  number	  was	  0.7;	  highest	  number	  of	  Paneth	  cell	  counted	  in	  a	  crypt	  bottom	  was	  2	  and	  the	  lowest	  was	  0.	  On	  the	  other	  hand,	  the	  corresponding	  control	  group	  of	  resveratrol	  50-­‐μM	  had	  in	  average	  4.7	  Paneth	  cells	  per	  crypt	  bud;	  highest	  number	  counted	  was	  12,	  and	  lowest	  was	  2.	  However,	  difference	  in	  Paneth	  cell	  count	  between	  the	  organoid	  group	  treated	  with	  100-­‐μM	  resveratrol	  in	  ENR	  media	  and	  its	  control	  group	  was	  larger.	  Strikingly,	  there	  were	  no	  Paneth	  cells	  visible	  when	  imaged	  under	  light	  microscope	  at	  40x	  objective	  in	  resveratrol	  100-­‐μM	  group,	  whereas	  its	  control	  group	  had	  organoid	  crypt	  bottoms	  possessing	  in	  average	  3.1	  Paneth	  cells	  (see	  Fig	  14).	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Average	  Number	  of	  Paneth	  Cell	  per	  
Organoid	  Crypt	  Bottom	   Ethanol	  50	  Resveratrol	  50uM	  Ethanol	  100	  Resveratrol	  100uM	  
Fig	  14.	  Average	  number	  of	  Paneth	  cells	  in	  crypt	  tips	  of	  organoids	  cultured	  in	  
resveratrol	  containing	  media	  for	  2	  days.	  Effect	  of	  resveratrol	  on	  Paneth	  cell	  count	  in	  the	  crypt	  bottoms	  of	  intestinal	  organoids	  was	  determined	  by	  counting	  Paneth	  cells	  under	  the	  microscope	  with	  40x	  objective.	  Average	  number	  of	  Paneth	  cells	  in	  experimental	  and	  control	  groups	  were	  calculated.	  Two-­‐tailed	  T-­‐test	  was	  used	  to	  determine	  the	  statistical	  significance	  of	  the	  results.	  Analysis	  showed	  that	  treating	  organoids	  with	  resveratrol	  of	  50-­‐μM	  or	  100-­‐μM	  in	  ENR	  media	  greatly	  reduced	  the	  number	  of	  Paneth	  cells	  located	  in	  a	  crypt	  bottom.	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Fig	  15.	  Paneth	  cells	  located	  at	  the	  crypt	  tips/bottoms	  of	  resveratrol	  treated	  
and	  non-­‐treated	  intestinal	  organoids.	  Crypt	  buds	  were	  imaged	  at	  20x	  for	  Paneth	  cells	  located	  in	  the	  crypt	  bottoms.	  Arrows	  pointing	  at	  the	  Paneth	  cells	  show	  that	  control	  organoids	  had	  visible	  Paneth	  cells	  residing	  at	  the	  crypt	  bottoms.	  However,	  organoids	  which	  were	  treated	  with	  either	  50-­‐μM	  or	  100-­‐μM	  resveratrol	  in	  ENR	  media	  had	  no	  Paneth	  cells	  located	  in	  the	  crypt	  bottoms	  as	  shown	  in	  the	  pictures	  above.	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5.	  Discussion	  
	  
5.1.	  Knocking	  Down	  Sirt-­‐1	  in	  Mouse	  Intestinal	  Organoids	  
	  
5.1.1.	  Analysis	  of	  Lentiviral	  Knockdown	  Efficiency	  in	  NIH	  3T3	  Mouse	  Fibroblasts	  	  Transducing	  wild-­‐type	  organoids	  is	  a	  very	  novel	  technique,	  optimized	  in	  Katajisto	  Lab	  only	  in	  August	  2014,	  and	  partly	  as	  a	  part	  of	  this	  thesis	  work.	  Therefore,	  produced	  lentiviruses	  were	  first	  tested	  on	  NIH	  3T3	  Mouse	  Fibroblasts.	  Without	  successful	  transduction	  of	  NIH	  3T3s	  it	  would	  not	  have	  been	  reasonable	  to	  advance	  into	  intestinal	  organoid	  transduction,	  since	  the	  latter	  is	  so	  much	  harder,	  tending	  to	  exhibit	  very	  low	  transduction	  efficiencies.	  	  According	  to	  the	  results	  obtained	  from	  Western	  Blotting	  and	  Image	  J	  Analysis,	  protein	  lysates	  obtained	  from	  lysed	  NIH	  3T3	  shRNA-­‐	  B2	  cells	  and	  NIH	  3T3	  shRNA-­‐	  A11	  cells	  contained	  very	  low	  amounts	  of	  SIRT1	  protein	  when	  compared	  with	  the	  analyzed	  lysate	  of	  control	  cells	  transduced	  with	  non-­‐targeting	  non-­‐SIRT1	  specific	  lentivirus.	  	  Upon	  discussion	  with	  my	  supervisor,	  I	  decided	  to	  continue	  my	  intestinal	  organoid	  transductions	  with	  lentiviruses	  named	  B2	  and	  A11.	  Lentivirus	  B3	  was	  not	  chosen	  as	  a	  candidate	  for	  further	  experiments	  since	  it	  displayed	  a	  lower	  SIRT1	  knockdown	  efficiency	  compared	  to	  other	  two	  lentiviruses.	  Advancing	  to	  the	  next	  stage	  with	  B2	  and	  A11	  had	  both	  its	  advantages	  and	  disadvantages.	  Since	  both	  lentiviruses	  exhibited	  very	  high	  knockdown	  efficiency	  in	  the	  target	  gene,	  especially	  lentivirus	  A11	  knocking	  down	  SIRT1	  almost	  by	  98%,	  it	  was	  expected,	  that	  we	  would	  observe	  close	  to	  maximal	  phenotypic	  alterations	  on	  the	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organoids	  and	  the	  regeneration	  rate	  of	  the	  crypts.	  Even	  though	  high	  knockdown	  efficiencies	  of	  these	  viruses	  might	  be	  considered	  as	  an	  advantage,	  this	  could	  also	  become	  a	  disadvantage	  as	  the	  high	  knockdown	  of	  a	  gene	  like	  SIRT1,	  which	  contributes	  to	  cellular	  proliferation	  and	  apoptosis,	  could	  actually	  be	  lethal	  for	  the	  intestinal	  organoids.	  Such	  an	  outcome	  would	  inhibit	  us	  from	  studying	  the	  role	  of	  SIRT1	  in	  crypt	  regeneration	  rate,	  and	  its	  impact	  on	  crypt	  length	  and	  width	  as	  well	  as	  Paneth	  cell	  count	  located	  in	  crypt	  tips.	  	  
5.1.2.	  Possible	  Effect	  of	  Sirt-­‐1	  Knock	  Down	  on	  Intestinal	  Organoid	  Size	  	  After	  intestinal	  organoids	  were	  transduced	  with	  chosen	  lentiviruses,	  puromycin	  selection	  method	  was	  used	  to	  identify	  the	  organoids,	  which	  were	  actually	  transduced.	  In	  the	  day	  of	  transduction,	  organoids	  were	  disintegrated	  into	  single	  cells	  or	  cell	  clusters.	  After	  this	  disintegration	  process,	  Lgr5+	  intestinal	  stem	  cells	  can	  be	  found	  as	  single	  cells	  or	  part	  of	  cell	  clusters.	  To	  prevent	  the	  spontaneous	  differentiation	  of	  stem	  cells	  in	  vitro,	  CHIR	  compound	  and	  Valproic	  Acid	  were	  utilized	  to	  trick	  stem	  cells	  into	  thinking	  they	  were	  in	  physical	  contact	  with	  Paneth	  cells	  by	  stimulating	  Wnt	  and	  Notch	  signaling	  pathways.	  Managing	  to	  infect	  a	  single	  stem	  cell	  with	  a	  SIRT1	  targeting	  lentivirus	  would	  provide	  us	  intestinal	  organoids	  with	  cells	  all	  containing	  the	  viral	  gene	  in	  their	  genome	  as	  a	  single	  stem	  gives	  rise	  to	  a	  full	  grown	  intestinal	  organoid.	  	  Two-­‐days	  post	  transduction	  of	  disintegrated	  intestinal	  organoids,	  there	  were	  organoids	  growing	  in	  all	  four	  experimental	  groups	  (no	  virus,	  non-­‐targeting,	  B2,	  and	  A11).	  An	  interesting	  difference	  observed	  between	  the	  organoids	  belonging	  to	  different	  groups	  was	  that	  the	  organoids	  with	  one	  of	  the	  two	  SIRT1	  knocking	  down	  lentiviruses	  were	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bigger	  in	  size	  compared	  to	  the	  organoids	  which	  were	  presumably	  transduced	  with	  non-­‐targeting	  virus	  or	  no	  virus.	  However,	  it	  was	  not	  yet	  proven	  if	  these	  organoids	  were	  actually	  transduced	  since	  the	  selection	  antibiotic	  puromycin	  was	  not	  yet	  applied.	  In	  previous	  research,	  conflicting	  results	  were	  reported	  on	  the	  ability	  of	  SIRT1	  to	  promote	  or	  inhibit	  cell	  proliferation	  and	  apoptosis	  in	  intestinal	  epithelium.	  According	  to	  a	  study	  that	  was	  done	  with	  mouse	  intestinal	  epithelium	  in	  normal	  physiological	  conditions,	  global	  knock	  out	  of	  SIRT1	  in	  mice	  promoted	  intestinal	  cell	  proliferation	  and	  suppressed	  cell	  apoptosis	  in	  the	  gut.101	  Along	  the	  same	  lines,	  organoids,	  which	  were	  presumably	  transduced	  with	  knockdown	  lentiviruses,	  were	  much	  bigger	  in	  lumen	  size	  compared	  to	  the	  control	  organoids.	  However,	  the	  significance	  of	  this	  observation	  is	  hard	  to	  judge,	  as	  it	  manifested	  prior	  to	  puromycin	  selection	  of	  infected	  organoids,	  and	  because	  organoids	  transduced	  with	  non-­‐targeting	  virus	  died	  during	  the	  selection.	  In	  case	  the	  intestinal	  organoids	  larger	  in	  lumen	  size	  would	  have	  demonstrated	  better	  survival	  than	  organoids	  with	  smaller	  lumen,	  this	  would	  have	  meant	  that	  the	  difference	  in	  lumen	  size	  was	  likely	  due	  to	  lentiviral	  knockdown	  of	  SIRT1.	  However,	  there	  was	  no	  trend	  observed	  between	  the	  organoid	  lumen	  size	  and	  survivability	  after	  puromycin	  addition	  as	  small	  and	  larger	  organoids	  were	  killed	  with	  similar	  frequencies	  by	  puromycin.	  
5.1.3.	  Selection	  of	  Successfully	  Transduced	  Mouse	  Intestinal	  Organoids	  	  After	  organoids	  went	  through	  the	  transduction	  procedure,	  puromycin	  selection	  was	  used	  to	  select	  the	  successfully	  transduced	  organoids	  and	  eliminate	  the	  non-­‐transduced	  ones.	  Organoids,	  which	  were	  not	  transduced,	  were	  all	  killed	  due	  to	  the	  puromycin	  effect	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as	  expected.	  Organoids,	  which	  were	  transduced	  with	  B2	  and	  A11	  knockdown	  viruses,	  had	  survivability	  rates	  of	  24%	  and	  12%,	  respectively.	  However,	  organoids,	  which	  were	  transduced	  with	  the	  non-­‐targeting	  non-­‐Sirt1	  specific	  control	  lentiviruses,	  were	  all	  killed	  upon	  applying	  puromycin,	  showing	  that	  the	  transduction	  of	  organoids	  with	  the	  control	  virus	  was	  not	  successful.	  As	  the	  same	  non-­‐targeting	  control	  virus	  was	  successfully	  used	  in	  the	  set-­‐up	  experimentes	  with	  NIH-­‐3T3,	  and	  presented	  similar	  infectivity	  as	  the	  B2	  and	  A11	  viruses,	  it	  is	  unclear	  why	  organoids	  were	  not	  infected	  with	  the	  control	  virus.	  The	  experiment	  was	  conducted	  only	  once	  (see	  below)	  so	  any	  error	  in	  the	  transduction	  protocol,	  or	  during	  selection	  could	  count	  for	  this.	  Also,	  as	  only	  12-­‐24%	  of	  organoids	  survived	  with	  A11	  and	  B2	  viruses,	  there	  was	  only	  a	  small	  window	  for	  infection	  by	  non-­‐targeting	  control	  to	  be	  detected,	  if	  it	  showed	  any	  lower	  transduction	  frequency.	  	  This	  situation	  left	  me	  with	  no	  control	  organoids	  surviving	  after	  puromycin	  selection	  but	  only	  organoids,	  which	  were	  transduced	  with	  SIRT1	  knockdown	  lentiviruses.	  It	  was	  an	  option	  to	  quit	  the	  experiment	  to	  start	  over	  and	  redo	  it	  but	  I	  chose	  to	  continue	  with	  the	  experiment.	  The	  experiment	  couldn’t	  also	  be	  redone	  quickly	  since	  there	  was	  no	  more	  control	  viruses	  left	  in	  the	  stock.	  I	  would	  need	  to	  prepare	  more	  control	  viruses	  together	  with	  knockdown	  viruses,	  since	  all	  viruses	  have	  to	  come	  from	  the	  same	  batch	  when	  doing	  a	  comparison	  study.	  I	  would	  also	  need	  to	  infect	  another	  set	  of	  NIH	  3T3	  cells	  with	  these	  new	  viruses,	  select	  the	  transduced	  ones,	  grow	  them,	  and	  perform	  another	  Western	  Blot	  and	  Image	  J	  Analysis	  to	  determine	  the	  Sirt1	  knockdown	  efficiency	  of	  these	  new	  viruses.	  This	  would	  be	  followed	  by	  an	  isolation	  of	  a	  new	  small	  intestine	  from	  a	  mouse	  and	  culturing	  the	  organoids	  in	  vitro	  for	  a	  week	  before	  the	  transduction	  could	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take	  place	  with	  no	  guarantee	  that	  the	  transduction	  would	  work	  perfectly	  this	  time	  since	  the	  protocol	  was	  very	  new	  and	  required	  more	  optimization	  to	  achieve	  higher	  transduction	  efficiencies.	  In	  short,	  in	  order	  not	  to	  repeat	  the	  work	  done	  in	  the	  past	  1.5-­‐2	  months,	  I	  decided	  to	  continue	  with	  my	  experiment	  and	  analyze	  the	  effect	  of	  Sirt1	  knockdown	  on	  my	  organoids	  without	  the	  control	  organoids,	  which	  could	  be	  considered	  as	  a	  shortcoming	  of	  this	  experiment.	  	  	  
5.1.4.	  Effect	  of	  Sirt-­‐1	  Knock	  Down	  on	  Mouse	  Intestinal	  Organoid	  Maintenance	  	  Successfully	  selected	  mouse	  intestinal	  organoids	  were	  cultured	  for	  another	  9	  days	  after	  the	  selection	  was	  complete.	  Even	  though	  the	  organoids	  were	  able	  to	  survive	  the	  selection,	  which	  indicated	  that	  they	  were	  successfully	  transduced,	  almost	  all	  of	  them	  either	  could	  not	  regenerate	  new	  crypt	  buddings	  or	  couldn’t	  regenerate	  and	  died	  in	  their	  lumen	  form.	  Organoids	  transduced	  with	  the	  A11	  lentivirus	  that	  knocked	  down	  SIRT1	  by	  98%	  were	  all	  dead	  or	  in	  lumen	  form	  13	  days	  after	  transduction	  (9	  days	  after	  puromycin	  selection	  was	  complete).	  Organoids	  transduced	  with	  the	  B2	  lentivirus	  that	  knocked	  down	  SIRT1	  by	  88%	  were	  almost	  all	  dead	  too,	  only	  2	  organoids	  surviving	  and	  regenerating	  new	  crypt	  buds.	  As	  I	  did	  not	  have	  the	  proper	  control	  (transduced	  with	  a	  non-­‐targeting	  virus)	  organoids,	  I	  can	  only	  compare	  the	  A11	  and	  B2	  transduced	  organoids	  to	  organoids	  that	  have	  not	  been	  transduced	  at	  all.	  Such	  un-­‐transduced	  organoids	  can	  be	  grown	  quickly	  to	  form	  miniguts	  that	  contain	  multiple	  crypt	  domains	  (see	  for	  example	  Figure	  10)	  and	  show	  no	  tendency	  to	  die	  over	  a	  short	  9-­‐day	  culture.	  	  The	  reason	  why	  transduced	  intestinal	  stem	  cells	  were	  able	  to	  form	  short-­‐term	  organoids	  but	  not	  regenerate	  crypt	  buds	  may	  be	  complex	  as	  SIRT1	  was	  attributed	  to	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contradicting	  roles	  as	  either	  tumor-­‐promoting/cell	  proliferative	  or	  tumor-­‐suppressor/cell	  proliferation	  inhibitor.	  	  However,	  an	  explanation	  to	  this	  result	  might	  be	  as	  follows:	  intestinal	  stem	  cells	  with	  SIRT1	  knockdown	  were	  able	  to	  form	  organoids	  and	  luminal	  structures	  because	  they	  were	  supplemented	  with	  Wnt	  ligand.	  Normally	  organoids	  do	  not	  need	  additional	  Wnt	  ligands	  as	  stem	  cells	  receive	  wnt	  –signals	  from	  the	  Paneth	  cells,	  but	  when	  organoids	  are	  dissociated,	  and	  Paneth-­‐ISC	  contacts	  are	  lost,	  cultures	  must	  be	  supplemented	  with	  Wnt3A	  for	  a	  period	  of	  1-­‐2	  days.	  Wnt	  ligand	  stimulated	  the	  Wnt	  signaling	  pathway	  and	  promoted	  cell	  proliferation	  and	  the	  formation	  of	  the	  organoids.	  The	  organoids	  were	  not	  dying	  because	  the	  presence	  of	  β-­‐catenin,	  a	  downstream	  effector	  of	  Wnt	  signaling	  pathway,	  was	  promoting	  the	  self-­‐renewal	  of	  intestinal	  stem	  cells	  after	  they	  were	  dividing	  and	  giving	  rise	  to	  a	  stem	  cell	  and	  a	  differentiated	  cell.	  β-­‐catenin	  can	  mediate	  the	  activation	  of	  Wnt	  target	  genes,	  promoting	  cell	  proliferation	  of	  the	  crypt	  epithelium.	  However,	  after	  organoids	  were	  selected	  with	  puromycin	  Wnt	  ligand	  was	  no	  more	  included	  in	  the	  organoid	  culture	  media	  in	  order	  to	  see	  the	  full	  and	  unique	  effect	  of	  SIRT1	  on	  mouse	  intestinal	  organoid	  maintenance.	  	  SIRT1	  is	  also	  a	  stimulator	  of	  Wnt	  signaling	  pathway	  and	  in	  the	  absence	  of	  Wnt	  ligand	  and	  SIRT1	  stimulation,	  intracellular	  β-­‐catenin	  levels	  might	  be	  steeply	  reduced	  and	  caused	  the	  differentiation	  of	  the	  stem	  cells	  into	  mature	  cells	  of	  intestinal	  epithelium.	  Inhibition	  of	  SIRT1	  was	  previously	  shown	  to	  inactivate	  β-­‐catenin	  in	  colorectal	  carcinoma	  cells.	  	  When	  there	  was	  no	  stem	  cell	  left	  to	  give	  rise	  to	  healthy	  differentiated	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cells	  due	  to	  the	  stem	  cells’	  quick	  differentiation	  caused	  by	  very	  low	  β-­‐catenin	  levels	  arising	  from	  lack	  of	  Wnt	  and	  Sirt1	  signaling,	  organoids	  started	  to	  die.	  	  	  Now	  the	  question	  is	  how	  can	  the	  two	  organoids	  manage	  to	  overcome	  SIRT1	  knockdown	  effect	  and	  regenerate	  crypt	  buddings	  even	  when	  Wnt	  ligands	  were	  removed?	  Surprisingly,	  the	  two	  organoids,	  which	  were	  able	  to	  survive	  and	  regenerate	  new	  crypts,	  had	  already	  been	  started	  to	  give	  rise	  to	  new	  buds	  in	  the	  presence	  of	  Wnt	  ligand.	  So,	  it	  is	  possible,	  that	  when	  Wnt	  ligand	  was	  no	  longer	  provided	  in	  the	  culture	  media,	  crypts	  managed	  to	  continue	  to	  further	  grow	  due	  to	  Wnt	  ligands	  produced	  by	  Paneth	  cells	  of	  the	  crypts	  and	  organoids	  were	  not	  killed	  by	  the	  severe	  SIRT1	  knockdown.	  However,	  the	  actual	  reason	  why	  these	  two	  organoids	  transduced	  with	  B2	  lentivirus	  were	  able	  to	  regenerate	  crypts	  and	  do	  this	  faster	  than	  other	  organoids	  cannot	  be	  fully	  explained	  with	  the	  experimental	  results	  in	  hand.	  One	  reason	  might	  be	  that	  these	  two	  organoids	  might	  have	  managed	  to	  mitigate	  the	  effect	  of	  the	  viral	  knockdown	  on	  their	  survivability	  by	  successfully	  silencing	  the	  virally	  integrated	  gene	  on	  their	  genome.	  Puromycin	  could	  have	  been	  reused	  again	  to	  see	  if	  all	  of	  the	  cells	  of	  these	  two	  organoids	  were	  still	  resistant	  to	  the	  selection	  marker.	  However,	  this	  was	  not	  thought	  on	  the	  right	  time	  by	  me	  and	  was	  not	  essayed.	  	  98%	  inactivation	  of	  SIRT1	  in	  mouse	  intestinal	  organoids	  might	  also	  have	  interfered	  with	  IIS	  signaling	  pathway,	  preventing	  the	  proliferation	  of	  intestinal	  epithelial	  cells	  and	  the	  regeneration	  of	  new	  crypt	  buddings.	  It	  has	  been	  previously	  shown	  that	  mice	  with	  global	  SIRT1	  deletion	  express	  severe	  growth	  retardation	  and	  reduced	  blood	  levels	  of	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free	  IGF-­‐I.99	  Severe	  reduction	  in	  SIRT1	  expression	  levels	  might	  have	  also	  severely	  reduced	  the	  functioning	  of	  IIS	  signaling	  pathways,	  leading	  to	  the	  death	  of	  the	  organoids.	  Even	  though	  reducing	  IIS	  signaling	  was	  previously	  shown	  as	  a	  defensive	  mechanism	  against	  aging36-­‐37,	  extremely	  low	  expression	  levels	  of	  the	  genes	  belonging	  to	  this	  pathway	  was	  shown	  to	  be	  lethal	  to	  organisms	  as	  it	  will	  greatly	  inhibit	  cellular	  proliferation	  and	  healthy	  functioning	  of	  the	  metabolism.38-­‐39	  	  	  Another	  reason	  why	  SIRT1	  knockdown	  intestinal	  organoids	  could	  not	  regenerate	  and	  die	  only	  after	  forming	  the	  luminal	  structure	  might	  be	  related	  to	  reductions	  in	  AMPK	  signaling	  pathway.	  AMPK	  plays	  significant	  role	  in	  improving	  lifespan	  by	  regulating	  energy	  homeostasis,	  stress	  resistance,	  and	  cellular	  housekeeping.45	  AMPK	  was	  also	  shown	  to	  prolong	  lifespan	  in	  lower	  organisms	  when	  upregulated.45	  SIRT1	  is	  known	  to	  engage	  in	  a	  positive	  feedback	  loop	  of	  activation	  with	  AMPK,	  higher	  SIRT1	  levels	  more	  AMPK	  will	  be	  activated.47	  In	  mouse	  intestinal	  organoid	  models	  with	  effective	  SIRT1	  knockdown,	  the	  activation	  signaling	  from	  SIRT1	  on	  AMPK	  might	  have	  disappeared.	  Very	  often	  aging	  is	  accompanied	  by	  reductions	  in	  AMPK	  signaling.46	  Thus;	  knockdown	  of	  SIRT1	  might	  have	  reduced	  AMPK	  signaling	  and	  speeded	  up	  the	  aging	  of	  intestinal	  organoids,	  causing	  them	  to	  die	  before	  they	  could	  regenerate	  new	  crypts.	  	  
5.2.	  Activating	  Sirt-­‐1	  in	  Mouse	  Intestinal	  Organoids	  By	  Applying	  Resveratrol	  
	  
5.2.1.	  Impact	  of	  Resveratrol	  on	  Mouse	  Intestinal	  Organoid	  Survivability	  	  	  Resveratrol	  is	  a	  candidate	  drug	  for	  treating	  aging-­‐associated	  diseases,	  especially	  Type-­‐2	  diabetes.	  Activation	  of	  SIRT1	  by	  resveratrol	  may	  be	  used	  as	  a	  treatment	  method	  in	  the	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future	  to	  ameliorate	  the	  healthspan	  of	  aging	  populations,	  which	  will	  be	  very	  likely	  to	  suffer	  from	  a	  variety	  of	  aging-­‐associated	  diseases	  including	  Type-­‐2	  diabetes,	  obesity,	  cardiovascular	  diseases,	  and	  cancer.	  	  In	  this	  study,	  we	  wanted	  to	  observe	  the	  role	  of	  SIRT1	  in	  mouse	  intestinal	  organoid	  maintenance.	  More	  specifically,	  we	  were	  interested	  in	  if	  SIRT1	  could	  alter	  intestinal	  crypt	  regeneration	  by	  regulating	  the	  proliferation	  and	  apoptosis	  of	  intestinal	  stem	  cells	  and	  Paneth	  cells.	  	  Applying	  different	  concentrations	  of	  resveratrol	  to	  fully	  functional	  and	  viable	  intestinal	  organoids	  displayed	  a	  possible	  negative	  effect	  of	  resveratrol	  on	  organoid	  viability	  and	  regeneration.	  Organoids,	  which	  were	  treated	  with	  highest	  concentration	  of	  resveratrol	  (200-­‐μM)	  in	  the	  experimental	  design,	  exhibited	  the	  lowest	  survival	  rate	  of	  only	  around	  7%,	  which	  is	  81%	  lower	  than	  the	  survivability	  rate	  of	  the	  control	  group.	  In	  concordance,	  while	  SIRT1	  can	  be	  targeted	  for	  activation	  to	  prevent	  the	  development	  of	  aging-­‐associated	  diseases,	  to	  enhance	  energy	  balance,	  and	  to	  regulate	  cell	  proliferation	  and	  apoptosis	  in	  many	  organisms,	  activating	  SIRT1	  high	  above	  it	  physiological	  levels	  was	  previously	  shown	  as	  lethal.101-­‐102	  	  	  
5.2.2.	  Resveratrol	  Effect	  on	  Crypt	  Regeneration	  	  	  Several	  metric	  were	  analyzed	  to	  determine	  if	  resveratrol	  affects	  crypt	  regeneration.	  	  First,	  we	  examined	  the	  effect	  of	  resveratrol	  on	  average	  number	  of	  crypts	  forming	  per	  organoid	  to	  determine	  if	  resveratrol,	  by	  activating	  its	  target	  gene	  SIRT1,	  can	  enhance	  or	  inhibit	  crypt	  regeneration.	  Despite	  the	  experimental	  groups,	  which	  received	  either	  50-­‐
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μM	  or	  100-­‐μM	  resveratrol	  in	  regular	  organoid	  culture	  media,	  possessed	  fewer	  crypts	  regenerating	  from	  organoid	  lumen	  compared	  to	  the	  control	  organoids,	  the	  difference	  was	  not	  found	  to	  be	  statistically	  significant.	  Thus,	  we	  concluded	  that	  SIRT1	  does	  not	  have	  a	  role	  in	  the	  number	  of	  crypts	  regenerating	  from	  an	  organoid.	  	  Next,	  we	  measured	  the	  average	  crypt	  length	  together	  with	  average	  crypt	  width.	  Resveratrol	  treated	  groups	  were	  found	  to	  have	  shorter	  crypts	  compared	  to	  controls.	  At	  50-­‐μM	  resveratrol	  was	  able	  to	  slow	  down	  the	  regeneration	  rate	  at	  a	  level	  of	  statistical	  significance,	  whereas	  at	  100-­‐μM	  the	  difference	  in	  crypt	  length	  was	  not	  statistically	  significant	  between	  resveratrol	  treated	  group	  and	  the	  control	  group.	  Shorter	  crypts	  typically	  indicate	  slower	  rate	  of	  proliferation	  by	  the	  two	  proliferative	  cell	  types	  of	  intestinal	  crypts:	  the	  ISCs	  and	  transiently	  amplifying	  cells.	  We	  did	  not	  address	  which	  type	  of	  cell	  was	  responsible	  for	  the	  reduced	  crypt	  length,	  but	  reduced	  proliferation	  by	  either	  cell	  type	  will	  also	  result	  in	  reduced	  regeneration,	  and	  could	  also	  explain	  the	  (non-­‐significant)	  trend	  towards	  fewer	  crypts.	  Finally,	  applying	  resveratrol	  to	  mouse	  intestinal	  organoids	  affected	  the	  width	  of	  the	  regenerating	  crypts	  at	  a	  great	  extent	  and	  statistically	  significant.	  Resveratrol	  treated	  organoids	  possessed	  narrower	  crypts	  compared	  to	  the	  controls	  at	  a	  level	  of	  statistical	  significance.	  Surprisingly,	  the	  difference	  was	  relatively	  bigger	  between	  organoids	  treated	  with	  50-­‐μM	  resveratrol	  and	  its	  controls	  compared	  to	  the	  difference	  in	  crypt	  width	  between	  the	  organoids	  treated	  with	  100-­‐μM	  resveratrol	  and	  its	  corresponding	  controls.	  Similar	  trends	  were	  seen	  with	  other	  used	  crypt	  measurements.	  We	  can	  not	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conclude	  whether	  this	  is	  due	  to	  SIRT1	  activation	  having	  maximal	  effects	  at	  50μM	  or	  due	  to	  the	  higher	  concentration	  of	  ethanol	  masking	  effects	  with	  100μM	  concentrations.	  
5.2.3.	  Effect	  of	  Sirt1	  Activation	  on	  Paneth	  Cell	  Proliferation	  	  We	  demonstrated	  that	  Sirt1	  activation	  by	  resveratrol	  to	  very	  high	  levels	  was	  lethal	  for	  mouse	  intestinal	  organoids.	  Sirt1	  activation	  also	  displayed	  growth-­‐inhibiting	  effect	  on	  regenerating	  crypts,	  leading	  to	  shorter	  and	  narrower	  crypts	  compared	  to	  controls.	  To	  get	  a	  better	  insight	  on	  why	  these	  crypts	  were	  narrower	  and	  also	  growing	  slower,	  we	  wanted	  to	  analyze	  the	  Paneth	  cell	  composition	  of	  crypt	  tips	  of	  intestinal	  organoids.	  	  Intestinal	  stem	  cells	  (ISCs)	  reside	  at	  the	  crypt	  bottoms/tips	  in	  the	  single	  cell	  layered	  intestinal	  epithelium.	  ISCs	  are	  in	  direct	  physical	  contact	  with	  two	  Paneth	  cells	  on	  both	  sides,	  which	  signal	  them	  to	  stay	  in	  the	  stem	  cell	  state	  and	  enable	  their	  self-­‐renewal	  ability.	  When	  stem	  cells	  lose	  contact	  with	  Paneth	  cells,	  they	  spontaneously	  differentiate	  into	  other	  cell	  types	  of	  intestinal	  epithelium.	  	  Paneth	  cells	  can	  easily	  be	  distinguished	  from	  other	  cell	  types	  by	  their	  granular	  structure	  under	  the	  light	  microscope	  with	  40x	  objective.	  Since	  ISCs	  are	  found	  in	  the	  middle	  of	  two	  Paneth	  cells,	  counting	  Paneth	  cells	  can	  give	  us	  an	  approximate	  result	  on	  the	  number	  of	  ISCs	  located	  in	  a	  given	  crypt	  tip.	  Additionally,	  growth	  of	  an	  intestinal	  crypt	  is	  driven	  by	  the	  cycles	  of	  proliferation	  and	  differentiation	  of	  intestinal	  stem	  cells.	  Possessing	  more	  stem	  cells	  can	  be	  considered	  beneficial	  in	  the	  beginning;	  however,	  it	  can	  also	  lead	  to	  a	  fate	  of	  faster	  growth	  and	  a	  quicker	  death	  for	  the	  organoids	  if	  these	  stem	  cells	  are	  actively	  proliferating	  and	  differentiating.	  Therefore,	  it	  might	  actually	  be	  more	  beneficial	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for	  an	  organoid	  to	  possess	  less	  but	  more	  dormant	  stem	  cells	  in	  order	  to	  extend	  its	  lifespan.	  	  My	  observation	  of	  Paneth	  cell	  numbers,	  and	  thus	  the	  number	  of	  stem	  cells,	  in	  a	  crypt	  tip	  can	  explain	  the	  slower	  growth	  in	  length	  and	  width	  in	  mouse	  intestinal	  organoids	  treated	  with	  resveratrol.	  We	  hypothesized	  that	  we	  would	  observe	  less	  Paneth	  cells	  in	  crypt	  tips	  of	  organoids	  treated	  with	  resveratrol	  since	  they	  exhibited	  narrower	  crypt	  tips	  compared	  to	  the	  control	  organoids.	  According	  to	  the	  observations,	  our	  hypothesis	  was	  right.	  Indeed,	  organoids	  that	  were	  treated	  with	  50-­‐μM	  resveratrol	  had	  an	  average	  of	  0.7	  Paneth	  cell	  per	  organoid	  tip,	  some	  crypt	  tips	  exhibiting	  no	  Paneth	  cell	  at	  all.	  Doubling	  resveratrol	  concentration	  to	  100-­‐μM	  reduced	  the	  visible	  Paneth	  cell	  number	  to	  0.	  On	  the	  contrary,	  the	  control	  organoids	  for	  50-­‐μM	  and	  100-­‐μM	  resveratrol	  had	  in	  average	  4.7	  and	  3.1	  Paneth	  cells,	  respectively.	  Therefore,	  we	  conclude	  that	  Sirt1,	  activated	  by	  resveratrol,	  controls	  the	  differentiation	  Paneth	  cells	  in	  mouse	  intestinal	  crypts,	  and	  therefore	  influences	  the	  number	  of	  stem	  cells	  that	  are	  dependent	  on	  contacts	  with	  Paneth	  cells.	  Reduced	  number	  of	  Paneth	  cells	  may	  also	  explain	  the	  reduced	  crypt	  width	  as	  Paneth	  cells	  are	  large.	  Even	  though	  almost	  no	  Paneth	  cell	  was	  observed	  in	  crypt	  tips	  of	  organoids	  treated	  with	  100-­‐μM	  resveratrol,	  we	  believe	  that	  there	  were	  actually	  some	  Paneth	  cells,	  or	  cells	  with	  Paneth	  cell-­‐like	  stem	  cell	  supporting	  activity,	  but	  that	  they	  were	  thinner	  and	  smaller	  compared	  to	  the	  normal	  size	  of	  a	  Paneth	  cell.	  Otherwise,	  there	  would	  not	  be	  any	  intestinal	  stem	  cell	  existing	  in	  these	  crypt	  tips,	  leading	  to	  the	  death	  of	  the	  organoid.	  That	  is	  actually	  what	  we	  think	  that	  happened	  in	  organoids	  that	  were	  treated	  with	  200-­‐μM	  resveratrol;	  overexpression	  of	  Sirt1	  mediated	  through	  resveratrol	  inhibited	  Paneth	  cell	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differentiation	  to	  an	  extent	  that	  there	  were	  no	  Paneth	  cells	  to	  create	  the	  niche	  required	  for	  stem	  cells	  to	  be	  able	  to	  self-­‐renew	  themselves.	  Furthermore,	  low	  Paneth	  cell	  number	  would	  lead	  to	  the	  differentiation	  of	  the	  accompanying	  stem	  cells	  and	  would	  eventually	  cause	  the	  death	  of	  organoids.	  In	  parallel	  to	  our	  findings,	  and	  while	  this	  thesis	  work	  was	  on-­‐going,	  Sirt1	  was	  also	  found	  to	  be	  a	  regulator	  of	  Paneth	  cell	  number	  in	  crypt	  tips	  of	  intestinal	  epithelium.106	  Mice	  with	  an	  intestinal	  specific	  Sirt1	  deficiency	  were	  found	  to	  possess	  more	  Paneth	  cells	  compared	  to	  controls.106	  However,	  I	  did	  not	  observe	  high	  increases	  in	  Paneth	  cell	  number	  in	  crypt	  tips	  of	  Sirt1	  knockdown	  organoids.	  Reason	  might	  be	  that	  the	  knockdown	  on	  the	  in	  vitro	  organoid	  cultures	  occurs	  without	  the	  native	  interactions	  between	  intestinal	  epithelium	  and	  mesenchymal	  cells,	  and	  that	  loss	  of	  Sirt1	  in	  this	  context	  may	  result	  in	  organoid	  death	  even	  if	  loss	  of	  Sirt1	  in	  vivo	  can	  be	  compensated	  and	  results	  only	  in	  overrepresentation	  of	  the	  secretory	  lineage	  cells.	  On	  the	  other	  hand,	  the	  findings	  by	  La	  Sasso	  et	  al.106	  are	  perfectly	  in	  line	  with	  my	  findings	  on	  the	  dramatic	  reduction	  of	  Paneth	  cell	  number	  with	  SIRT1	  activation	  by	  Resveratrol.	  It	  will	  be	  interesting	  to	  address	  if	  the	  reduced	  number	  of	  Paneth	  cells	  due	  to	  SIRT1	  activation,	  that	  I	  discovered,	  could	  also	  indicate	  that	  Resveratrol	  reduces	  the	  number	  of	  cycling	  Lgr5+	  stem	  cells,	  and	  could	  therefore	  have	  strong	  effects	  on	  intestinal	  homeostasis	  and	  for	  example	  tumor	  incidence.	  Intestinal	  organoids	  that	  were	  treated	  with	  100-­‐μM	  resveratrol	  had	  much	  less	  Paneth	  cells,	  and	  thus	  stem	  cells,	  compared	  to	  the	  control	  organoids.	  Consistently,	  organoids	  treated	  with	  100-­‐μM	  resveratrol	  exhibited	  a	  slower	  rate	  of	  crypt	  regeneration,	  possessing	  shorter	  and	  narrower	  crypts	  compared	  to	  controls.	  However,	  the	  remaining	  stem	  cells	  in	  resveratrol	  treated	  groups	  (except	  200	  μM)	  were	  still	  able	  to	  support	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proliferation	  and	  differentiation	  and	  enable	  the	  organoid	  to	  grow	  and	  regenerate	  new	  crypt	  buddings.	  Surprisingly	  even	  the	  complete	  lack	  of	  observed	  Paneth	  cells	  in	  100μM	  treated	  organoids	  did	  not	  result	  in	  significant	  reduction	  in	  crypt	  numbers	  per	  organoid.	  However,	  repeat	  experiments	  are	  necessary,	  as	  also	  crypt	  number	  was	  showing	  a	  trend	  for	  lower	  values.	  
5.3.	  Concluding	  Remarks	  on	  Thesis	  Results	  	  In	  this	  project,	  we	  essayed	  to	  identify	  the	  role	  of	  Sirt1,	  an	  NAD+-­‐dependent	  deacetylase	  known	  to	  regulate	  vital	  cellular	  mechanisms	  such	  as	  proliferation	  and	  apoptosis,	  energy	  balance,	  and	  glucose	  and	  lipid	  metabolism,	  in	  the	  maintenance	  of	  mouse	  intestinal	  organoid	  models.	  We	  investigated	  the	  role	  of	  Sirt1	  by	  taking	  two	  different	  approaches.	  First,	  we	  knocked	  down	  Sirt1	  gene	  in	  mouse	  intestinal	  organoid	  models	  by	  transducing	  the	  organoids	  with	  lentiviruses.	  Later,	  we	  performed	  drug-­‐mediated	  activation	  of	  Sirt1	  by	  utilizing	  commercially	  available	  resveratrol.	  In	  both	  approaches,	  we	  observed	  how	  the	  inhibition	  or	  the	  activation	  of	  Sirt1	  would	  affect	  mouse	  intestinal	  organoid	  maintenance	  and	  whether	  the	  organoid	  model	  would	  benefit	  from	  overexpression	  and/or	  deactivation	  of	  Sirt1	  gene.	  More	  specifically,	  we	  were	  interested	  in	  how	  activation	  and	  deactivation	  of	  Sirt1	  would	  alter	  the	  regeneration	  of	  intestinal	  crypts	  and	  their	  growth	  rate.	  To	  understand	  the	  results	  we	  observed,	  we	  tried	  to	  make	  a	  connection	  between	  the	  Paneth	  cell	  and	  intestinal	  stem	  cell	  composition	  of	  intestinal	  crypt	  tips	  with	  the	  rate	  of	  regeneration	  and	  the	  size	  and	  number	  of	  regenerated	  intestinal	  crypts.	  We	  demonstrated	  that	  severe	  knockdown	  of	  Sirt1	  gene	  inhibited	  the	  regeneration	  of	  new	  intestinal	  crypt	  buddings	  and	  caused	  the	  death	  of	  the	  intestinal	  organoids.	  Severe	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deactivation	  of	  Sirt1	  might	  have	  reduced	  the	  activity	  of	  complex	  signaling	  pathways	  such	  as	  Wnt	  signaling,	  IIS	  signaling,	  and	  AMPK	  signaling	  pathways,	  which	  possess	  significant	  roles	  in	  regulating	  many	  different	  metabolic	  activities.	  Moreover,	  activating	  Sirt1	  much	  above	  its	  physiological	  levels	  also	  exhibited	  lethal	  impact	  on	  intestinal	  organoids.	  We	  showed	  that	  activating	  Sirt1	  with	  resveratrol	  slowed	  down	  the	  regeneration	  rate	  of	  intestinal	  organoids,	  leading	  to	  the	  formation	  of	  organoids	  with	  crypts	  of	  shorter	  and	  narrower	  in	  size	  compared	  to	  controls.	  We	  also	  demonstrated	  that	  Sirt1	  was	  able	  to	  slow	  down	  regeneration	  by	  controlling	  the	  proliferation	  of	  Paneth	  cells	  located	  in	  intestinal	  crypt	  tips.	  Activating	  Sirt1	  reduced	  the	  number	  of	  Paneth	  cells	  located	  in	  the	  crypts	  of	  intestinal	  organoids.	  Since	  Paneth	  cell	  number	  in	  a	  crypt	  is	  positively	  correlated	  with	  stem	  cell	  number	  we	  can	  also	  claim	  that	  Sirt1	  activation	  reduced	  the	  number	  of	  intestinal	  stem	  cell	  in	  a	  crypt	  tip.	  Activation	  of	  Sirt1	  to	  very	  high	  levels	  phenocopied	  gene-­‐loss-­‐of	  function	  that	  we	  observed	  in	  the	  knockdown	  model,	  by	  completely	  inhibiting	  the	  formation	  of	  Paneth	  cells	  and	  destroying	  the	  niche	  required	  for	  stem	  cells	  to	  self-­‐renew	  in	  intestinal	  crypts	  and	  leading	  to	  the	  death	  of	  the	  mouse	  intestinal	  organoids.	  In	  conclusion,	  severe	  knockdown	  of	  Sirt1	  gene	  through	  shRNA	  lentivirus	  method	  and	  very	  high	  activation	  of	  Sirt1	  by	  resveratrol	  exhibited	  similar	  lethal	  effects	  on	  mouse	  intestinal	  organoids;	  whereas,	  relatively	  lower	  overexpression	  of	  Sirt1	  via	  resveratrol	  exhibited	  results	  that	  deserve	  to	  be	  further	  investigated	  in	  the	  context	  of	  intestinal	  epithelium	  dynamics.	  Relatively	  low	  level	  of	  activation	  of	  Sirt1	  slowed	  down	  the	  rate	  of	  regeneration	  by	  regulating	  the	  proliferation	  of	  Paneth	  cells	  in	  crypt	  tips	  of	  mouse	  intestinal	  organoids.	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